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A B S i a A C T 
I I has been demonstrated that HM& i s not onXy 
capable of decreasing t o t a l serum choles tero l but a l so 
decreases e s t e r cho le s t e ro l , t o t a l e s t e r i f i e d f a t t y s ^ d s 
and t r i g lyce r ide s of normocholesteroleiaic animals, HMO 
i s e f f e c t i v e both o ra l ly and i n t r a p e r i t o n e a l l y , the l a t t e r 
mode of adminis t ra t ion appears more e f f e c t i v e . The 
compound d i s t i n c t l y lovers the serum choles te ro l content 
of cholesterolemlc animals but f a i l s to in f luence the 
l i v e r choles terol content of normal as well as choles-
terolemic r a t s . 
HMQ a lso blocked the experimentally induced hyper-
cholesterolemia both i n serum and l i v e r . I t i s readi ly 
absorbed when administered o ra l ly or i n t r a p e r i t o n e a l l y to 
the r a t s because lowering of serum choles te ro l coomences 
within 12 hours of HH6 adminis t ra t ion. The e f f e c t i s 
maximum between 16-24 hours. 
HMG i s a lso capable of decreasing the serum t o t a l , 
e s t e r cho le s t e ro l , t o t a l es te r i f ied , f a t t y ac ids , phospho-
l i p i d s and t r ig lyce r ides content of hyperlipemic r a t s to 
the extent of 46%, 33^, 19% and 30% r espec t ive ly . 
On the bas is of h i s t o l o ^ c a l and h is topathologica l 
s tud ies of UM&*treated norfflocholesterolemic and hyper-
choles te ro l emlc r a t s , i t has been concluded that HMG has 
no toxic e f f e c t s on the c e l l u l a r a rch i t ec tu re of l i v e r , 
hea r t , kidney, ajdrenals, spleen, ao r t a , brain and lungs, 
i^rthermore adminis t rat ion of HMO to hypercholesterolemic 
r a t s causes quicker reversa l of f a t t y l i v e r changes 
towards normalcy. The appreciable increase i n the hepatic 
re t i cu loendothe l i a l c e l l s of HM0-treated animals has been 
a t t r i b u t e d to p ro tec t ive e f f e c t of HMG agains t hypercholes-
terolemia and f a t t y i n f i l t r a t i o n i n l i v e r . 
In a preliminary pharmsu^ological screening i t has 
been found tha t HMG i s completely i n e r t and therefore i t 
i s superior to most of the known hypocholesterolemic and 
hypolipemic drugs which have harmful e f f e c t s . 
In choles te ro l - fed r a t s , the hepat ic HMG-CoA 
hydrolase (EC a c t i v i t y i s 3-5 fold increased. 
I t has, the re fo re , been suggested that the r i s e i n enzyme 
a c t i v i t y i s primary manifesta t ion of choles te ro l feeding; 
the secondary being the i n h i b i t i o n of i^ 6->CoA reductase 
(BC 1 . I . 1 .34 ) a c t i v i t y by HMG released in vivo due to 
increase i n HMG-CoA hydrolase a c t i v i t y . 
On the bas i s of enzyadc s tud ies i t has been 
hypothesized tl)at choles terol feed-back control lolght 
ac t by increas ing the a c t i v i t y of UMG-CoA hydrolase, 
thereby increas ing f r e e HMG and decreasing choles tero l 
b iosynthes is due to simple subs t ra te analog competition. 
On the bas i s of s tud ie s , so f a r made, i t i s 
concluded that HMG may be successful ly used in the t r e a t -
ment of hypercholesterolemia and hyperlipemia provided 
i n men the substance ac t s i n the same way and i s well 
t o l e r a t ed . 
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I I I . I H f E O B U C T I O H 
G e n e r a i 
A white c r y s t a l l i n e substance discovered i n human 
ga l l s tones , about 200 years ago, was named choles ter ine 
by Chevreul (1816) who shoved that i t was nonsaponif iabie 
in contras t to o ther animal waxes. When Berthelot (1859) 
demonstrated the presence of an alcohol group i n the 
molecule, the more descr ip t ive name choles terol became 
general ly acceptable* 
Although the empirioal formula of Cg-^ H g^O was 
proved, in 1888, on the bas i s of an analysis of choles te ro l 
ace ta te dibromide (Rein i tzer , 1888), i t was not before 1932 
tha t the s t r u c t u r a l formula of choles te ro l was f i r s t 
e s tab l i shed . 
Cholesterol i s one of the most widely d i s t r ibu ted 
compounds in the animal kingdom (Doree, 1909). I t i s 
always present i n ve r t ebra tes , o f t e n in i nve r t eb ra t e s 
and recently has been discovered in algae. I t occurs 
normally f r e e or combined Xn t i s sues and s e c r e t i o n s . 
notably Xiveri b r a in , sk in , adrenals , bile^ blood and 
adipose depos i t s . I t i s found pa tha loglca l ly i n b i l i a r y 
c a l c u l i , sebaceous cysts and atiiaroaatus blood vessel walls. 
Cholesterol forms the chief component of the non-
sapoa i f iab le f r a c t i o n of blood. I t i s present i n the 
blood both in the form of the f r e e alcohol and i n the form 
of e s t e r . About 73% of the plasaa choles te ro l i s noraal ly 
e s t e r i f i e d i n the case of man. In the plasma, cho les te ro l 
i s o rd inar i ly combined with the unsaturated f a t t y ac ids . 
A large proportion of the choles te ro l i n human plasma i s 
l ikewise i n combination with p ro te in . 0ofi&£ui ^ 
Cl949t 1950) separated l ipopro te ins containing choles te ro l 
from rabbi t and human sera by u l t r a c e n t r i f u g a t i o n . I t i s 
believed that the protein combinations with cho les te ro l 
represent the forms in which choles terol can exert i t s 
atherogenic act ion (Gofman et t 1950). When an excess 
of d i e t a ry choles tero l i s fed , i t r e s u l t s i n hypercholes-
terolemia (Peters and Van Slyke, 1946) as well a s f a t t y 
l i v e r s i n r a t s (Best and Hidont, 1933i Best e t 1934} 
Cook, 1936? Swell and F l i ck , 1953). Habbits maintained 
on a d ie t containing choles tero l and b i l e s a l t s not only 
develop hypercholesterolemia (Swell and F l i ck , 1953) but 
also a the rosc le ros i s (!?urner, 1933} Turner and jM.<iwell, 
193^)* In the ease of guinea p igs , hypercholesteroleioia 
together with f a t t y i n f i l t r a t i o n i n l i v e r i s developed 
when s t e r o l i s given (Cook, 1936} Okey, 1942), Wissler 
e t a l ,« (1953) reported a commercial d ie t which produced 
lipomatus les ions in the coronary a r t e r i e s of r a t s , i f 
fed for a year , Knudson (1921) reported an increase in 
f r e e choles terol i n both the plasma and the corpuscles , 
when e i the r f r e e or e s t e r i f i e d choles tero l i s fed to dogs. 
However, e s t e r choles te ro l remains unaf fec ted . There i s 
con^derab le evidence i n l i t e r a t u r e t ha t various l i p i d 
components other than choles terol i n the blood may be 
a l t e r ed by the Inges t ion of cho les te ro l d i e t containing 
f a t . Page and Bernhard (1935) showed that when choles te ro l 
i n ol ive o i l was fed to r a b b i t s , the plasma phospholipids 
were increased. This was f u r t h e r confirmed by Weinhouse 
end Hirsch (1940a)who noted that the neu t ra l f a t and 
choles te ro l f r a c t i o n s of the blood were increased, when 
f a t added choles tero l d i e t s were fed to r a b b i t s . Vermenlen 
and coworkers (1942) a lso reported s imilar type of r i s e in 
non-cholesterol f r a c t i o n s of serum l i p i d s of r abb i t s fed 
choles te ro l dissolved in sunflower-seed o i l , Dubach and 
Hi l l (1946) noticed an increase i n a l l blood l i p i d s , when 
r a b b i t s were given e i t he r lanol in or cho les te ro l . 
In a r t e r i o s c l e r o s i s , where blood choles te ro l 
together with other l i p i d s i s s i g n i f i c a n t l y increased , 
there I s loss i n the e l a s t i c i t y of a r t e r i e s , associated 
with thickening and hardening of t h e i r wal l s . This 
condit ion i s usual ly a manifestat ion of hypertension. 
The type of a r t e r i o s c l e r o s i s produced experimentally i n 
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animals i s r e fe r red as a the rosc le ros i s , where only the 
intima i s involved. The atheromatous les ions (or * patches*) 
present i n t h i s layer contain small drople ts of l i p i d 
ma te r i a l . The a the rosc le ro t i c l e s ion i s a complicated 
a f f a i r . Wh®a f u l l y developed, i t i s comprised of a cons i -
derable var ie ty of s t ruc tu res and substancest blood and 
blood products, f ib rous scar t i s sue , calcium depos i t s , 
complex carbohydrates, cho les te ro l , f a t t y acids and l i p o -
p ro t e ins . Apparently the f a t t y acids and choles te ro l are 
the c ruc i a l substances responsible for the development of 
l e s i on , because they provoke inflauamation and scar r ing of 
the a r t e r i a l wai l . Cholesterol i s indeed an i n e v i t a b l e 
suspect , because the formation of the a the rosc le ro t i c 
l e s ion i s e s sen t i a l l y an inflammatory response to t h i s 
substance. The iavolvement of choles te ro l i a the disease 
has been demonstrated in many d i f f e r e n t ways, Experisaents 
have been perforoed to produce the disease by choles te ro l 
feeding i n many animals, including r a b b i t s , r a t s , guinea 
p igs , chiclcens, dogs and monlceys. In almost every case 
i n vhich the disease i s induced experimentally the animal 's 
serum shows a r i s e i n choles te ro l as a prelude to the 
a the rosc l e ros i s . In primates the disease exh ib i t s a l l the 
f ea tu res that occur i n human beings. I t has a l so been 
shown tha t pa t i en t s su f f e r ing from peptic u l ce r t rea ted 
with a d ie t r i ch in millc and cream had elevated l eve l s of 
choles te ro l i n t h e i r serum aad suffered twice as high a 
r a t e of hear t a t tacks from coronary a the rosc le ros i s as 
u lcer pa t i en t s who did not use t h i s d i e t . Conversely, 
pa t i en t s with mult iple myeloma, a malignant disease that 
tends to lower the serum choles terol level as one of i t s 
e f f e c t s , have an unusually low ra t e of hear t a t t a c k s . 
People dying of so-cal led wasting diseases ( e s s e n t i a l l y 
malnutr i t ion) show a low l i p i d content i n t h e i r a r t e r i e s , 
which suggests that the loss of f a t may reduce t h e i r 
a the rosc le ro t i c l e s ions . On the other hand people s u f f e r -
ing from a iseases or condi t ions , that are usual ly accom-
panied by a high cholesterol^such a s , d iabe tes , nephrosis , 
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heredi ta ry elevat ion of l i p i d s i a the body, tend to 
develop a therosc le ros i s a t an e a r l i e r age and more exten-
s ive ly , than UBual. There i s ample c l i n i c a l evidence tha t 
diabetes mel l i tus i s a condit ion character ized by an exces-
s ive incidence of a the rosc le ros i s . However, evaluation of 
the ro le of diabetes i a atherogonesis i s d i f f i c u l t since 
hypertension i s coauBonly associated with the dysfunct ioa of 
l i p i d metabolism as in the d iabe t ic s t a t e . 
Contrary to expectat ions, alloxan-induced diabetes 
was found to reduce atheromatosis in cholesterol ized 
r abb i t s (Duff aad McMillan, 1949} HcGill and Holman, 1949). 
Although choleeterol- induced lipemia was r a the r enhanced 
by a l loxan, the pro tec t ive e f f e c t on a therogeaesis has 
been a t t r i b u t e d to the d iabe t ic s t a t e and not to alloxan 
as such (Cook ^ a l . , 1954? Buff gt. a l . , 1954). The 
apparent immunity of alloxanized rabb i t s to the atherogenic 
stimulus of h i ^ serum choles te ro l level has been explained 
by Pierce (1952). An important contr ibut ion to t h i s 
problem has been made by Ushe r et (1961), who r e a f -
firmed that a l loxan-diabetes i n h i b i t s atherogenesis i n 
choles terol ized rabb i t s and observed that renal hyperten-
sion i n conjunction with d iabetes and choles tero l feeding 
leads to more severe a o r t i c a the rosc le ros i s than that i n 
conjunction with choles terol feeding alone. This e f f e c t 
of hypertension in d iabe t ic animals was not accompsLnied 
by any aggravation of l ipetaia. In s tudies on alloxanized 
r a t e , fed a d ie t containing h i ^ amount of f a t , d r a s t i c 
hyperlipemia was observed i n the d iabe t ic animal thaoi i n 
the controls (Kalant and Harland, 1961). However, the 
degree of l i p i d deposit ion i n the vessels was not s i gn i -
f i c a n t l y a l t e red by the d iabe t ic s t a t e . 
Morrison and Johnson (1950) observed that the 
average choles terol content of the coronary a s t e r i e s of 
p a t i e n t s who had died of acute coronary thrombosis was 
four times the average for a group of cont ro l p a t i e n t s . 
Sumerous worisers have shown tha t choles te ro l deposit ion 
or i t s accumulation i n these atheromatous patches takes 
place by preference (Schonheimer, 1924b{ Rosenthal, 
19341 t e a r y , 194t | HcArthur, 1942). The amount of choles-
t e ro l deposited in the aor ta of presumably normal person 
has been shown to increase with advancing age(Burger, 
1928; Rosenthal, 1934). l a f a c t , Bragdon (1952) showed 
tha t spontaneous a the rosc le ros i s may be present i n aging 
r a b b i t s . Because of the predominance of cho les te ro l i n 
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the atheromatous masses, i t i s believed tha t deposit ion 
of choles tero l i n the a r t e r i a l wall i s probably a t t r i b u t -
able to hypercholesterolemia* Bjorksten (1952) demons-
t ra ted tha t the Intima of f r e sh hog aor tas can be made to 
adsorb and r e t a i n choles terol from a suspension provided 
that the intima was f i r s t t r ea ted v i t h ce r t a in c ross -
l ink ing agents , of which lead ace ta te i s most e f f i c a c i o u s . 
On the bas is of these r e s u l t s , i t has been hypothesized 
tha t the primary cause of cho les te ro l deposit ion and the 
subsequent pathologic complications of the a r t e r i e s may 
be a chemical process a f f e c t i n g the protein c o n t ^ t on the 
l i n i n g of the a r t e r i e s . In ju ry may also c ^ s e the forma-
t ion of atheromas (Schlichter ^ a l . , 1949). Duff (1935) 
demonstrated that i n ju ry to the intima precedes the 
deposit ion of choles terol i n the blood ves se l s . In t h i s 
case the primary cause may not be hypercholesterolemia or 
disturbance in choles terol metabolism, but a chemical 
disturbance i n the t i s sue which favours the deposit ion i n 
a p a r t i c u l a r a rea . This disturbance may be exaggerated 
by h i ^ l e v e l s of plasma choles te ro l and thus ac t s as a 
contributory f ac to r of a the rosc le ros i s . Cholesterol 
deposit ion in ar ter iei l walls was demonstrated in v i t r o 
by wilens (1951) who showed that a v i s i b l e l i p i d r e t en -
t ion ocoured I f noma! hMmaA hlood serum was f i l t e r e d 
through the walls a t noriaal a r t e r i a l pressures fo r 24 
hours or longer. I t was estimated tha t of the 
choles tero l was retained in t ramural ly . Therefore, i t 
was suggested tha t a the rosc le ros i s r e s u l t s f roo f i l t r a -
t ion of serum through the wal ls of the a r t e r y . Bince 
the isa^or port ion of choles te ro l f a i l s to enter the 
a r t e r i a l intiraa due to i t s combination with large protein 
Biolecttles, i t i s postulated tha t only f r e e choles tero l 
can pass i n to the a r t e r i a l wal l s . Peters and Van Slyke 
(1946) postula ted that presence of cho les te ro l i n a thero-
matous changes does not prove that hypercholesterolemia 
or any disturbance in choles tero l metabolism i s the only 
cause of the depositxon. furthermore Chernick £jt 
(1949) as well as Werthessen e^ (1954) have shown 
that choles terol can be synthesized within the a r t e r i a l 
wal l . 
Anitschkow (1925) f a i l e d to produce a the rosc le ros i s 
i n ca t s or dogs by choles terol feeding. Ste iner ^ 
(1949) obtained pos i t ive r e s u l t s when th iourac i l i s also 
given, fhese r e s u l t s would ind ica t e that atherogenesis 
10 
may occur more readilj? when hypo function of the thyroid 
gland i s there . This r e s u l t was cons is tent with the 
report of Eatz and coworkers (1955) that thyroid hormone 
i s able to supress both hypercholesterolemia and a thero-
genesis* Hormones other than those associated with thyroid 
are a lso ac t ive i n r e l a t i o n to atherogenesis e . g . , 17-
hydroxycorticosterone (compound F) i n t e n s i f i e s hypercholes-
terolemia and hyperlipeiffiia i n cho les te ro l - fed chicks, 
AOTH i n large doses dupl ica tes these e f f e c t s . Estrogens 
when given with choles terol d ie t completely i n h i b i t s the 
a the rosc le ro t i c developments. Moreover the pre-es tabl ished 
l e s ions were reversed in chicks under estrogen treatment. 
Estrogen a lso causes reduction in t o t a l c h o l e s t e r o l j l i p i d 
p r a t i o (Katz e t , 1955). 
Pyridoxine (Bg) i s a lso associated with the develop-
ment of a the rosc le ros i s . Ihus i n monkeys, Binehart and 
Greenberg (1949, 1951) succeeded i n producing a therosc le -
r o s i s by means of a pyridoxine de f i c i en t d i e t , while 
prolonged feeding with choles terol f a i l e d to produce 
s i gn i f i c an t l e s ions . Later s tudies (Greenberg and 
Rinehart , 1951) revealed that a grea ter degree of choles-
terolemia was present in the pyridoxine d e f i c i e n t monkeys 
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kept on choles terol than the normal animals receiving 
l a rge r q u a n t i t i e s of cho les te ro l . 
Gould et e a , , ( t95 l ) believed that an equilibrium 
ex i s t s between plasma choles te ro l and l i v e r cho les te ro l , 
M.* (1951) f a i l e d to show any such re l a t ionsh ip 
between the l eve l of l i v e r and plasma choles te ro l and 
the i r r e l a t i v e su scep t i b i l i t y to a the rosc l e ros i s . However, 
S ipers te in and Fagan (1964) have demonstrated maximum 
increase in serum and l i v e r choles tero l l e v e l s of various 
species when fed choles terol along with b i l e s a l t s , Ihe 
highest l eve l s of plasma choles tero l were found in chickens 
and rabb i t s (both are suscept ib le to a t h e r o s c l e r o s i s ) , 
whereas highest average value have been reported in the 
l i v e r s of hamsters and r a t s , which are r e s i s t a n t to a the ro-
s c l e r o s i s (Goldmm, 1950? Al tschul , 1950; Marx e t a l . . 
1951). This may be due to the f a c t that hamsters and r a t s 
have the a b i l i t y to s tore the choles te ro l more e f f i c i e n t l y 
in the l i v e r than chickens or r a b b i t s . 
Although a hypercholesterolemia following choles* 
t e r o l f eed i i ^ i s associated with the production of an 
a the rosc le ros i s in r abb i t s , there axe con f l i c t i ng views 
regarding the a r t e r i o s c l e r o s i s prevalent i n maa, Leary 
(1954) reported that on autopsy the l e s i o n s , obtained 
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from the blood vesse ls of r a b b i t s having an experimentally 
produced a the rosc le ros i s aitd those obtained from the 
» 
coronary a r t e r i e s of a r t e r e o s e l e r o t i c p a t i e n t s , were 
s imi l a r . Peters and Van Slyke (1946) pointed out that 
experimental a therosc le ros i s of rabb i t s d i f f e r s from the 
diseased condition i n man by the speed of development and 
a lso unusual su scep t ib i l i t y of the former to iodine and 
to the a c t i v i t y of the thyroid gland. 
Similar diagreements, as whether hypercholestero-
lemia i s an invar iab le concomitant of hypertension i n man 
or hypertension follows the manifes ta t ions of hypercholes-
terolemia, has always been a subject matter of d iscuss ion. 
Several workers have reported tha t cho les t e ro l , as well a s , 
a l l blood l i p i d s are increased i n hypertension (Fahrig 
and Wacker, 1932; Wacker and Fahrig, 1932| Harr i s , 1949). 
Alford (1949) found tha t coronary hear t disease i s a sso-
c ia ted with heredi tary hyperlipemia, Ger t l e r and Garn 
(1950) observed tha t serum choles terol was higher in 
males having experienced myocardial i n f a r c t i o n . In the 
coronary diseased groups, both choles terol and phospho-
l i p i d s were increased in the serum, but the cho les te ro l : 
Phospholipid (C/P) r a t i o was l ikewise increased, i n d i c a t -
ing that the r i s e in phospholipid had not kept pace with 
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tha t of cho les te ro l . I t i s suggested that the f a c t o r s 
favouring the deposi t ion of cho les te ro l in the int ima 
are enhanced because of the lack of s u f f i c i e n t phospho-
l i p i d to act as a co l lo id s t a b l i z e r . I t i s important to 
report t ha t hypercholesterolemia e x i s t s in a var ie ty of 
diseases other thaji hypertension and in ce r t a in cases 
noroal choles te ro l l eve l may occur i n hypertension provided 
diseases l i k e n e p h r i t i s i s absent {Harris and Mpkin* 
1930| Alvarez and Keuschlosa, 193tj Page a l . t 1936; 
Gofman, e t , 1951} Buff and Meissner, 1951). There-
f o r e the occurance of hypertension i s not supposed to be 
an ade<|uate proof f o r the existence of a the rosc le ros i s 
(Peters and Van Slyke, 1946), 
I t i s now well recognized that a number of " r i sk 
f ac to r s " may be involved in the development of a thero-
s c l e r o t i c hear t d isease . These f a c t o r s include hyper-
cholesterolemia (serum choles te ro l 260 mg/lOO ml or above)» 
hypertension (d i a s to l i c blood pressure of 95 mm or above), 
marked obes i ty , heavy c i g a r e t t e smoking, d iabetes me l l i t u s , 
and a family h i s tory of vascular disease (Kannel et a l . , 
1961t Stamler e t 1962, 1963} Doyle ^ a l , , 1962), 
Recently there has been growing suspicion tha t d ie ta ry 
14 
carbohydrates, by v i r tue of an inf luence on the serum 
t r i g lyce r ides and phospholipids, may play a ro l e i n the 
developmeat of a the rosc le ro t i c disease (Albrink, 196^; 
Kuo and Basse t t , 1965i Ostrander ^ , 1965). A cor re -
l a t i o n between elevated serum t r ig lyce r ide and choles te ro l 
l eve l s and coronary a r t e ry disease has been shown (Albrink 
and Man, 1958, 1959| Carlson, t960| Albrink e t a l . , 1961f 
Havel and Carlson, 1962| Albrink, 1962, 1963{ Feldman and 
Wallace, 1964)* Experiments have been performed to demons-
t r a t e an increas ing C/P r a t i o i n pa t i en t s s u f f e r i n g from 
conditions known to be predisposing to a the rosc l e ros i s 
(Ahrens and Hunkel, 1949)* The choles tero l fed r a t s 
(Berger ^ a l • , 1965), chickens (Chaikoff e t a l . , 1948| 
Orma, 1957), r abb i t s (Dury, 19571 Wang et a l , , 1954) and 
choles te ro l - fed th iourac i l t r ea ted dogs (X^vidson a l « , 
1949) have been shown to possess higher G/P r a t i o s than 
comparable con t ro l s . However, the e t io log ic s ign i f icance 
of serum t r i g lyce r ides and phospholipids awaits f u r t h e r 
c l a r i f i c a t i o n . In f a c t , the serum t o t a l cho les te ro l 
level appears to remain the best s ingle pred ic tor of 
r i sk i n coronary hear t disease (Kannel e^ a l . , 1964), 
p r ior to the development of myocardial i n f a r c t i o n . The 
survival r a t e of pa t i en t s following myocardial i n f a r c t i o n , 
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however, was not i&flueneed by the plasma ooncentratlons 
of choles terol ( L i t t l e e t , 1%5). The proport ional i ty 
between plasma l i p i d s and l i p i d s of atheromata (Schonkeimer, 
1926| Weinhouse aad Hirsch, 1940t))Page, 19411 Head and 
Gottzet I96I) strongly suggests tha t the souroe of most 
of the l i p i d s of atheromatous plaques i s the serum. 
From the foregoing discussion, i t i s c lea r tha t 
a therosc leros is can not be explained simply in terms of 
choles tero l . However, from the data so f a r avai lable 
one can def ine t ly conclude tha t involvement of the choles-
terol in t h i s disease i s of utmost importance. In con-
junction with various l i p i d s i t may be ca l led as "VILLAIN" 
in the diseases associated with hypercholesterolemia and 
hyperlipemia. 
Control of Cholesterol Biosynthesis 
In normal humans, as well as i n other species, the 
blood cholesterol leve l remains constant within narrow 
l i m i t s , although t h i s can be ra ised by addit ion of large 
amounts of cholesterol i n d i e t , t h i s r e l a t i v e constancy 
appears to be maintained by a negative feed-bacK cont ro l . 
I t has been known since the experiments of Gould (1931), 
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Tofflkins g t , ^ . , <1953)# I»aiigdon and Bloch (1953) and 
Pranta e t a l . (1954) that choles tero l feeding to r a t s 
causes a marked depression i n the r a t e of hepat ic synthesis 
of choles tero l by such animals, the e lucidat ion of the 
d e t a i l of homeostasis i s of obvious importance, both from 
the biochemical and as well a s , perhaps, from c l i n i c a l 
stand point of view. I t i s now possible to def ine most 
of the reac t ions of choles te ro l synthesis from ace ta t e . 
A s impl i f ied sequence of the biosynthesis i s given i n 
i lg* t , , more d e t a i l information may be found in a number 
of recent reviews (Kritchevsky, 1958| Gould, 1958f Popjak 
and Cornforth, I960} Tchen, t960| Por te r , 1961j Clayton, 
1965). 
Using r a t l i v e r preparat ions , @ould and Swyryd 
(1966) were able to demonstrate three s i t e s of i n h i b i t i o n 
of choles tero l synthes is which i s depicted in f i g . 2 . , 
as S^, Sg and The maximum capac i t i e s of normal r a t 
l i v e r homogimates and s l i c e s to synthesize cho les te ro l 
from mevalonic acid (MVA) were shown to be f a r g rea te r 
than from ace ta te . Conseqiuently the s i t e s of I nh ib i t i on 
a f t e r mevalonate (Sg and S^) probably do not have a 
s i g n i f i c a n t e f f e c t on the overa l l r a t e of choles tero l 
synthes i s i n the i n t a c t choles te ro l - fed animals. I t has 
Fig. 1. Scheme showing some of the metabolic 
funct ions of ace ta te and i t s conversion to 
cholesterol* 

Fig, 2, S i t e s of i nh ib i t i on of Cholesterol 
biosynthesis produced, by choles te ro l feeding. 
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a lso been shown tha t choles terol feeding r e s u l t s i n a 
marked i n h i b i t i o n of cho les te ro l synthes is i n man 
(Bhattathiry and S ipe r s t e in , 1963) which leaves no 
(question that humsmis a lso possess a feed-back system 
a t l e a s t as sens i t ive as tha t of lower animals. The 
major s i t e of choles te ro l feed-back regulat ion has now 
been de f ine t ly shown to be the hydroxyraethylglutaryl 
coenzyme A(HMG-CoA) reductase (EC t . 1 , 1 , 3 4 ) ( s ipe r s t e in 
and Fagan, 1964). From the works of Bucher e t al .(1960> 
and Mnn (1967) on the assay of HMG-CoA reductase a c t i v i t y 
i n l i v e r s from f a s t ed , t r i t o n - t r e a t e d r a t s and c h o l e s t e r o l -
fed r a t s , i t i s f u r t h e r confirmed that t h i s enzyme i s 
concerned in the overa l l r e f l a t i o n of choles terol biosyn-
t h e s i s , A se r i e s of experiments mainly due to Beher e t 
(1961) show the operation of a double feed-back mechanism 
i n regula t ion of cho les te ro l b iosynthes is . The main c a t a -
bo l i c pathway of cholesterol^ the conversion to b i l e ac ids , 
seems to be control led by a feed-back s imi lar to tha t of 
cho les te ro l synthes is . As shown i n Fig. 3 . t the two feed-
back cont ro l s are considered to be complementary (Gould, 
1959). 
Fig. 5, Double feed-back i o h i b i t i o n of Cholesterol 
b iosynthes is . 
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Inh ib i t o r s of Cholesterol Biosynthesis 
In the l a s t two decades concerted attempts have 
heen made by Biochemists, JE&thologists, Cl in ica l n u t r i -
t i o n i s t s and I n t e r n i s t s to inves t iga te the ro le of various 
drugs i n combating hypercholesterolemia and a the rosc l e ros i s . 
Since hypercholesterolemia and hyperlipemia are prelude 
to a the rosc le ros i s , drugs or agents capable of cor rec t ion 
of these two abnormali t ies without any evidence of advanced 
a the rosc le ros i s would be of considerable he lp . The e f f e c t 
of var ious hypocholesteroloaic and hypolipemic agents , i n 
regress ing the pre-es tabl ished a the rosc le ro t i c l e s i o n s , 
would a lso be of great benef i t in the treatment of advanced 
a r t e r i o s c l e r o s i s . 
Taking blood l i p i d l eve l s as the main measurable 
parameter of l i p i d turnover in the body i t has been e s t a -
bl ished that many types of hypercholesterolemia are the 
r e s u l t of a p r io r e levat ion i n plasma t r i g lyce r ide s and 
phospholipids (Friedman ^ , 1962). I t i s well known, 
however, tha t e f f e c t i v e i n h i b i t o r s of choles terol biosyn-
t h e s i s w i l l lower not only choles terol l e v e l s but a lso the 
l e v e l s of l ipopro te in as a whole. Of the three main 
possible ways of lowering body cho le s t e ro l , i n t e r f e r ence 
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with r a t e l i a d t t n g s tep i n b iosyathes is (HMQ-CoA to MVA) 
seems the most promising one (Gould, 1960| MlgicoTsky, 
1962). The other two p o s s i b i l i t i e s , i . e . , s t imulat ion 
of choles te ro l excret ion and degradation to b i l e ac ids , 
i n h i b i t i o n of dietary choles tero l absorption or reabsorpt ion 
of b i l i a r y choles terol appear l e s s f e a s i b l e . Any change 
i n choles tero l absorption or degradation, a t l e a s t i n i t i a l l y , 
i s compensated fo r by the l i v e r which i s the main source 
of plasma choles te ro l (jPriedman et . , 1951). In the 
following pages some important i n h i b i t o r s of choles te ro l 
biosynthesis have been discussed. Ihese compounds are 
e i t h e r in use as hypocholesterolemic drug or have the ra -
peut ic p o t e n t i a l i t y i n the treatment of hypercholestero--
lemla and hyperlipemia. 
A. I nh ib i t o r s Acting Between Acetate And Hevalonate 
( i ) gC-Phenylbutyrate and Related Compounds - In 1953 
Redel and Cottot (1953) reported that oc-phenylbutyrate 
had a hypocholesterolemic e f f e c t i n normal r a t s , which 
was l a t e r on confirmed by Bargeton et a l . (1954). Cot te t 
e t a l . (1954) found that t h i s compound was also e f f e c t i v e 
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i n hypercholesfeerolemia of aiaa. Ifc appeared l i k e l y , 
from the work of Steinberg and Fredrickson tha tc jC-
phenylbutyrate i n h i b i t s the f i r s t s tep i n choles terol 
b iosynthes is , i . e . , ace ta te a c t i v a t i o n . The other d e r i -
va t ive of t h i s drug, ^ -benaa lbu ty r io acid and oC-methyl-
Y-pheaylbutyric acid were shown to i n h i b i t choles te ro l 
b iosynthes is (Ganoaica ^ a l . , 1961). The s i t e of ac t ion 
of a l l these phenyl der iva t ives seem to be CoA dejpendent 
r eac t ions pr ior to HMG-CoA formation. (Steinberg and 
Fredrickson, I955t 1956| Masters and Steinberg, 1958). 
However, t h i s i nh ib i t i on may not be of any s iga i f i cance 
i n r e l a t i o n to choles terol biosynthesis as acetyl-CoA 
may a l so be involved in other b iosynthet ic r eac t ions . 
Gallo e t (1963) found that 2,3*dimethyl-5-
phenyl-2- t rans-4- t rans pentadienoic acid i n h i b i t s choles-
t e r o l synthes is , presumably at iMG-CoA or MVA l e v e l . I t 
was a lso shown to cause t r ans i en t lowering of plasma 
choles te ro l l eve l s i n r a t s . Shapiro a t . (1962) 
observed the hypocholesterolemic e f f e c t s of cC-indan-
4-oxybutyric ac id . 
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< i i ) S ico t in ic Acid and i t s Derivat ives - l a 19551 
Altschul observed that administrat ion of la rge doses of 
n i c o t i n i c acid protected choles terol«fed r abb i t s from the 
development of hypercholesterolemia and l i p i d deposi t ion 
i n the aor ta (Altschul et. , 19555 Altschul and Hoffer , 
t955)* He fu r t he r observed tha t adminis t ra t ion of la rge 
doses of t h i s vitamin decreases serum choles te ro l i n 
hypercholesterolemic pa t i en t s (Altschul md Hoffer , 1958). 
These r e s u l t s were confirmed and extended, i n p a t i e n t s 
(Parsons e t a d . , 1956t Miller ejb , 1958} Eottke £ t a l . » 
1962) and i n var ie ty of animals (Merril and Lemley-Stone, 
1957| 0aylor ^ a l . » I960), Rats vere found to be unres -
ponsive to niacin (Friedman and Byers« 1959). C l in ica l 
s tud ies have indica ted tha t depression of serum phospholipids 
(aurian and Adlersberg, 1959)t t r i g lyce r ide s (Miller e t a l> . 
1960), a n d - l i p o p r o t e i n s (Oalbraith e t a l , , 1959) may be 
associa ted with n i c o t i n i c acid adminis t ra t ion. The mode 
of ac t ion of n i c o t i n i c acid has been subject of a recent 
review by Goldsmith (1962), n i co t in i c acid may act p r io r 
to the formation of mevalonic acid (Gamble and v r i gh t , 
1961). 
Secently, the c l i n i c a l use of aluminum n ico t ina te 
has been advocated as a means of obtaining reduction i n 
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serum cho l e s t e ro l , without vascular and g a s t r o i n t e s -
t i n a l s ide e f f e c t s . (Tribiano and Spencer, 1962)* On 
feeding Hexanlci t , the hexaester of i n o s i t o l and n i co -
t i n i c acid to hyperlipemic p a t i e n t s , a decrease i n blood 
l i p i d was observed (Schulse, 1962). Mesoinositol hexani-
co t ina t e C£aised 28^ reduct ion i n t o t a l serum cho le s t e ro l 
in normal r a b b i t s , | n v i t r o incorpora t ion s tud ies 
suggest tha t mesoinositol hexanicot inate i n h i b i t s the 
conversion of ace t a t e to mevalonic acid (Hakamura, t963) . 
Blanco ^ ad. (1965) showed tha t Complaiain, a der iva t ive 
of n i c o t i n i c ac id decreases blood cho les te ro l as well as 
o ther blood l i p i d s . Secently tfakasa ^ (1966) 
repor ted that dlwC-tocopheryl n i c o t i n a t e causes decrease 
i n t o t a l serum cho les t e ro l l e v e l s with improvement of the 
sub jec t ive symptoms, when given to hypercholesterolemic 
p a t i e n t s . I n j e c t i o n of th i^ compound to mice aecreased 
the acetate-1->C^^ incorpora t ion i n t o hepat ic c h o l e s t e r o l , 
but had no e f f e c t on mevaloiiate-2<-C^^ incorpora t ion , 
i n d i c a t i n g i n h i b i t i o n between ace t a t e and mevalonate. 
( i i i ) Benzyl H-benzylcarbethoxyhydroxamate (W-398) -
Berger and Coworkers (1963) have reported t ha t W-398 
w i l l reduce serum and l i v e r l i p i d s , i n cho l e s t e ro l - f ed 
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r abb i t s and hypercholesterolendc weanling r a t s . However, 
i t s i g n i f i c a n t l y e leva tes l i v e r choles te ro l l eve l s i n 
normocholesterolemic r a t s with no e f f e c t on serum l e v e l s 
(Kritchevsky eaid Tepper, 1966). A marked weight l o s s was 
a lso observed. I t i s believed tha t tf-398 l i m i t s the 
conversion of iffiG-CoA to mevalonate (Douglas, 1964)* 
Goenzyme Q - The decreased incorporat ion of ace t a t e 
i n t o cho le s t e ro l , with no e f f e c t on mevalonate incorpora-
t ion in coenzyme Q-fed animals, suggest that i t blocks 
some biosynthet ic s tep between ace ta te 'and mevalonate 
common to both coenzyme Q and choles te ro l (Josfai et a l . « 
1965). 
(v) Q«"b8ngoylthiamine d i sn l f i de (BTPS) - Nakamura (1966) 
reported that i n f ec t ion of BTDS to mice decreased the 
incorporat ion of acetate-1-G^^ i n t o hepatic choles terol 
with no e f f e c t on incorporat ion of mevalonic 
In mice receiving a d i e t supplemented with cho le s t e ro l , 
adminis t ra t ion of 20 mg/Kg BTDS suppressed the increase 
i n blood and hepat ic choles tero l l e v e l s . These r e s u l t s 
suggest tha t hypocholesterolemic ac t ion of the compound 
may be due to i n h i b i t i o n of choles te ro l biosynthesis 
between ace ta te and mevalonate. 
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B. Mevalonic Acid Analogs. 
In an attempt to i n t e r f e r e s p e c i f i c a l l y with the 
metabolism of mevalonic acid, the common precursors i n 
the biosynthesis of s t e r o l and other s te ro id compounds» 
several ant imetabol i tes of MVA have been discovered. Of 
a Bumi^er of stxiictujral analogs of MVA syntheslz&d and 
tes ted by Stewart and fefoolley (1959) i n a Lactobaci l lus 
acidophi lus system, 4-methyXmevalonic acid was p a r t i -
cu la r ly act ive i n i n h i b i t i n g MVA dependent growth of the 
organism. However, t h i s coapound as well as some others 
f a i l e d to e f f e c t cho les te ro l synthesis i n mice (Stewart 
and Woolley, 1961). 
Mentzer e^ a l . (1956) showed a 30JS reduction i n 
hepat ic choles terol l eve l s of r a t a f t e r adminis t ra t ion of 
•X 
A-'^.j-methylpentenoic ac id . Per t inent to the present 
d iscuss ion , Gey and assoc ia tes (1957) found that 
methylpentenoic acid and A'^-jnoetl^l-S-hydroxypentenoic 
acid inh ib i t ed the incorporat ion of ace ta te i n t o choles-
t e r o l . Weiss e t a l . (1961) found that 3»methyl-3-.hydroacy-
2 "5 pentenoic ac id , A -3-methylpentenoic acid and A ^ - 3 -
methylpentenoic ac id , a l l inh ib i ted the conversion of 
mevalonate to choles tero l by r a t l i v e r homogenates, the 
o 8 
hydroxy acid was aost e f f e c t i v e . The most potent MVA 
antagonist so f a r described appears to be ^-hydrosy-^-
fXuoroaethyX -releroiactone (3-fluromevaIoniG acid) 
(Singer e | e^.» 1959| Tschesche and Machleidt, I960). 
Among f a t t y ac ids , ac t ing as MVA antagonis ts (Wright, 
1957)<^biphenylbutyric acid has been shovrn to i n h i b i t 
choles te ro l synthesis ^ vivo (Ranney, 1958). Oara t t in i 
e t a l , (196t) claimed tha t d i f f enes i c acid <2-^4-b i phenyl J ' ' 
^ —4— hexemic ac id) in f luences experimental a thero-
s c l e r o s i s as well as reduces serum l i p i d l eve l s in man and 
dog. Klimov ^ (1967) showed that 2-phenyl-3-^ethyl-
2-pentenoic acid and 2-phenyl-3-oethyl-3-hydroxypentanoic 
acid respect ively inh ib i t ed non-competitively and compe* 
t i t i v e l y incorporat ion of MVA in to c h o l s t e r o l . Although 
2-phenyl-3-methyl-3,5-.dihydroxypentanoic acid had l i t t l e 
e f f e c t on HVA incorpora t ion , i t s i g n i f i c a n t l y suppressed 
choles te ro l b iosynthes is , presumably by i n h i b i t i n g ace ty l 
CoA formation. 
C. I n h i b i t o r s Acting Between Mevalonate And Squalene 
Vanadium - Vanadium decreased the incorporat ion of 
acetate-l-^C^^ in to choles terol by r a t and rabb i t l i v e r 
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in v i t r o as well as Jji yivp (Curraa, 1954| Gujrran and 
Coste l lo , 1956). Moreover, the l eve l s of serum, l i v e r 
and a o r t i c choles tero l was lower i n animals receiving 
Vaaiadium with a h i ^ choles tero l d ie t (Mountain e t a l , , 
1956)* Vanadium was found anti*>atherogenie i n cockerels 
and chickens ( lades and Gallo, 1957| I.oustalot e t a l , « 
1961). the locus of vanadium ac t ion has been assumed at 
the squalene synthetase leve l (Azamoff e t a l .« 1961). 
According to Holmes (1961) the HVA kinase reac t ion may 
represent the ac tua l s i t e of ac t ion . The ava i lab le 
evidences strongly suggest that i n humans the hypocIndiestero-
lemic proper t ies of vanadium re su l t primarily from i t s 
a b i l i t y to i n t e r f e r e with choles terol biosynthesis (Holmes, 
1964). 
( i i ) Terpenes - In 1961 Pletscher ^ (1961 > showed 
tha t I '-methylnerolidol and 2-dihydronerolidol are ac t ive 
i n decreasing .Mebermaa - Burchard • pos i t ive s t e r o l s i n 
the serum, but not i n the l i v e r , of normal r a t s . The 
i i ^ i b i t i o n of choles te ro l b iosynthes is , presumably a t the 
mevalonate kinase leve l by compounds r e l a t ed to fa rneso ic 
acid has been extensively reviewed (Holmes, 1964)* 
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( i i i ) Benzmalecene -» t h i s cc^poajad 
ch iorophenyl -propylJ oaleamic ac id) has been shown by Huff 
and G i l f i l i a n (1960) %o non-cofflpetifciYeljr i n h i b i t MVA conirer-
s ion to choles te ro l i n r a t l i v e r homogenates, on o ra l admi-
n i s t r a t i o n , i t lowers plasma choles terol i n r a t s and dogs 
(Tennent 1960)» I t i s also e f f e c t i v e i n c l i n i c a l 
hypercholesterolemia, but with some side e f f e c t s (Bergen 
£ t a l * , t960} Sachs et 1960). The s i t e of i n h i b i t i o n 
of benzmalecene has been shown between isopentenyl pyro-
phosphate and farnesyl pyrophosphate (Holauss, 1961). 
According to lack and tfeiner (1965)» i t i n t e r f e r e s with 
choles te ro l ajetab<iiisiB by reducing the ATP l e v e l s necessary 
for phosphate t r a n s f e r reac t ions . Although the compound 
has been shown to e f f e c t i v e l y reduce serum choles terol 
l e v e l s of hypertensive p a t i e n t s , the undesirable s ide 
e f f e c t s ru le out i t s usefu lness as a therapeut ic agent . 
( iv ) SKF 3KF 3301 and SKF 7732»-A^ - Many e s t e r 
and e ther de r iva t ives of d ie thy l -o r dimethylaiainomethanol 
markedly i n h i b i t the i n v i t r o conversion of MVA to choles-
t e ro l and a l so e f f e c t i v e l y decrease serum choles te ro l l e v e l s 
in mice, r a t s , dogs and monkeys (Mck e t , 1960{ 
Oreenberg e j ^ j ^ . , I960), Three of the most ac t ive compounds 
o t 
a r e ^ -diethylaminoethyldiphenylpropylacetate hydrochloride 
(SKF 525-A), 2,2-dipheayl-1 ^-din^thylaiBinoethoxy) pentane 
hydrochloride (S£f 3301-A) and fcris (2-diinethyl amino e thy l ) 
phosphate tr ihydrochloride (SEjP 7752-A^). I t appears that 
these re la ted compounds mainly a f f e c t the conversion of 
isopentenyl pyrophosphate to presqualene polyprenols 
(Holmes and Beatz, 1960j Holmes, 1964). SKF 525-A and 
SKF 3301-A were found to reverse f a t t y i n f i l t r a t i o n of 
l i v e r (fiice and Greenberg, t960). 
(v) Sulfonyl Ureas - In ra t l i v e r homogenates, conver-
sion of acetate-C^^ to cholesterol has been shown to be 
inh ib i ted by tolbutamide], chloropropamide, metahexamide 
and pbenethylbiguanide (McDonald and Dalidowice, 1962). 
Apparently, the inh ib i t ion of s t e ro l biosynthesis by such 
hypoglycemic agents occurs a f t e r the forsiation of MVA but 
before the squalene formation. 
S<malenes - Pletscher et a l . (1961) demonstrated 
/ 
that among unnatural der ivat ives of squalene, only 1»1-
dimethylsqualene depresses l i v e r cholesterol i n r a t s . 
o 2 
( v i i ) HepatocataXaee {Caperase) - I t has been reported 
tha t i t causes a considerable reduction of c i r c u l a t i n g 
choles te ro l i n humans and experimental animals receiving 
the enzyme by intramuscular in;Jection(Puig-Muset ^ a l .> 
I960). Caravaca and assoc ia tes (1963) showed tha t caperase 
i n h i b i t i o n s i t e i s between mevalonate and sq.ualene. The 
caperase^induced lowering of blood choles tero l occurs 
without any s i g n i f i c a n t e f f e c t on the t r i g lyce r ides and 
phospholipids, 
D. I n h i b i t o r s Acting Between Lanosterol And Cholesterol 
( i ) Triparanol - HER - 29, 
phenyl>«1-£"*p~tolyl^»2-'/f*p--chlorophenyl__7 ethanol) 
produces a marked lowering of serum and l i v e r choles te ro l 
l eve l s <Blohm ^ 1959). Blohm and Mackenzie (1959) 
showed that i t i n h i b i t s choles tero l synthesis beyond 
squalene. Evidence i s now accumulating tha t t r ipa rano l 
may i n h i b i t side chain reduction a t several points 
from lanos te ro l via zymosterol to desmosterol (Steinberg 
and Avlgsua, I960). Although t r ipa rano l g rea t ly reduces 
the l eve l of avai lable cho les te ro l , i t causes accumulation 
of desmosterol which i s d e f i n i t e l y atherogenic (Blankenhom, 
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I961i Avigan and Steinberg, 1962f Herndon and Siperstein# 
1963) l a oan as well as in experimental animals. Therefore 
t h i s compound i s no longer used i n hypercholesterolemia 
therapy. 
( i i ) Role of Biethylaminoalkyl Grouping - A charac te r -
S t ic par t of the t r iparanol molecule i s . t h e -OCHgCHgH(CgH^>2 
side chain. This radica l i s present i n several compounds 
with a hypocholesterolemlc a^ t iv i ty^ cyanostilbene 
der iva t ive bearing the diethylamlnoethoxy side chain 
(Hughes ©t a l . ,1962) and 1-dimethylaminoethyl-4-benzyl-
piper idine (IN 379) ( O ' D e l l ^ t , 1962). The l a t t e r 
has been shown to be ant ia therogenic i n r a b b i t s . An ether 
der iva t ive of dimethylaminoethanol, (3^-/3^-dimethylamino-
e t h o x y ^ androst-S-en-IT-one) has a s i g n i f i c a n t hypocholes-
terolemlc e f f e c t i n r a t s (Gordon e t s d . , 1961). This 
compound as well as i t s ^ - d i e t h y l der iva t ive (Ph i l l i p s and 
Avigan, 1963) i n h i b i t both desmosterol reductase and 
lanos te ro l reductase a c t i v i t i e s , 
(iii) Trans-1.4-bis(2«'Chlorobenzylaminomethylcyclohexane-
di HCl (Ay * 9944^ - I t inhibits hepat ic choles te ro l 
synthesis between Ismosterol and choles terol without 
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a f f e c t i n g the eazyme involved i n the reduct ion of A. 
bond. Ay-.9944 i n h i b i t s the enzymic t ransformation of 
7-dehydroGholesterol to cho les te ro l i n r a t l i v e r homo-
geaa tes (Eraial £ t , 1964a), The compound i s ac t ive 
i n lowering serum s t e r o l l e v e l s i n r a t s , p ig s , dogs, 
pigeons, monkeys and r a b b i t s (Chappel e t a l . , 1964)* 
( i v ) S tS^dibenzylethylenediamine - The compound i s 
e f f e c t i v e i n lowering serum s t e r o l s i n hypercholes tero-
lemic r a t s . The s i t e of ac t ion i s a t the l e v e l of the 
conversion of 7--dehydrocholesterol to cho les te ro l (Kraml 
e t a l . , 1964b). 
E. Miscellaneous Dru^s Affecting Cholesterol Synthesis 
( i ) 1«>i>^hlorophenylpentylsuccinate (AF-42$) - Palazzo 
and a s s o c i a t e s (1961) reported t ha t AF-425 i s a potent 
hypocholesterolemic agent fo r Triton-induced hypercholes-
terolemia i n r a t s . I t markedly i n h i b i t s the a c e t a t e 
and mevalonate incorpora t ion i n to c h o l e s t e r o l . Al l the 
ava i l ab l e evidences suggest t ha t the compound m i ^ t 
block cho les te ro l b iosyn thes i s a t more than one s i t e . 
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( i i ) A ^ Cfaolestenone - I t has been shovoi tha t 
feeding of several s t e ro ids causes marked depression 
i n the capacity of l i v e r s l i c e s from d i f f e r e n t animals, 
to incorporate acetate-1-G^^ in to choles terol (TomkLns 
e t I d . , 19531 Steinberg and f redr ic l tson, 1956). Steinberg 
- 4 
and Fredrickson showed that ^ -cholestenone i n h i b i t s 
the ^ vivo incorporat ion of ace ta te i n to cho les t e ro l , 
Cholestenone a lso induced an appreciable lowering of the 
serum choles te ro l i n r a t s , dogs and chickens (Tomkins 
e t a l . « 1957)* The exact locus of act ion i s not known. 
4 
A -Cholestenone has no c l i n i c a l s igni f icance because 
i t causes accumulation of dihydrocholesterol , which has 
atherogenic proper t ies (Nichols £ t , 1955). 
< i i i ) Androstene Derivatives - Large doses of methyl 
tes tosterone and 17 »methyltestosterone lower the serum 
choles te ro l l e v e l s i n dogs, swine and r a t s (Furman e t a l , , 
1957} Cox and Hale, I960} Abell and Mosbach, 1962). 
Rubin and white (1959) showed tha t the ra te of i nco r -
poration of aceta te i n to choles tero l by l i v e r s l i c e s of 
cas t ra ted animals receiving tes tos terone propionate was 
s i g n i f i c a n t l y lower. A - androstene-17o<^-ol-3-one-17yS-
Oic acid and /^^- tes to lac tone were a lso e f f e c t i v e i n 
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i nh ib i t i ng the synthesis of choles tero l from ace ta te 
and blocked the conversion of MVA to choles te ro l (Singer 
e t , 1959). However, the s i t e of act ion of these 
compounds i s not yet c l e a r . 4-chloro-17oC-iBethyl-19-
nor tes tos terone (SKF 6612) lowered the ra t serum choles-
t e r o l leve l (Holmes, 1964). SKF 6612 was found e f f e c t i v e 
i n i n h i b i t i n g the ^ v i t r o conversion of ace ta te to MVA, 
MVA to sq,ualene and i t s conversion to cho l e s t e ro l . I t 
has been suggested that t h i s compound exer ts i t s hypo-
cl«)lesteroleffiic e f f e c t i n r a t s by i n t e r f e r i n g a t one or 
more s i t e s of choles terol synthes is . However, d e f i n i t e 
mechanism i s s t i l l obscure. 
( iv ) Psychotropic Drugs - Eeceatly Yakubovskgiya and 
Kiseleva (1961 ) reported that chlorpromazine decreased 
the l i v e r choles tero l l e v e l s of pigeons and a lso inh ib i t ed 
the r a t e of choles terol b iosynthesis . I t seems highly 
possible that chlorpromazine also i n h i b i t s the e s t e r i f i -
cat ion of f a t t y acids withcC-glycerophosphate, 
(v) Bthyl Chlorophenoxyisobutyrate (CHB) - In 1962 
Thorp and Waring (1962) reported tha t GPIB adminis t ra-
t ion to r a t s resul ted in reduction of serum and l i v e r 
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choles te ro l l eve l s . Oral adminis t ra t ion of CPIB 
produces excel lent sustained hjrpocholesterolemic and 
hypolipemic e f f e c t s i n man (HelXman e t , 1963)* 7He 
a b i l i t y of cnB» to lover postprandial plasma opt ica l 
density as well as t r i g lyce r ides and l ipopro te ins 
(Strisower and Str isower , 1964)> suggests an act ion of 
t h i s drug on l ipoprote in l i p a s e . The mechanism i s 
believed to involve e i the r induction or increase of 
l ipopro te in l ipase or blockade of an i n h i b i t o r of that 
enzyme. Apparently the compound has an ac t ion on the 
blood c l o t t i n g mechanism as well as on l ipopro te in l i p a s e . 
When CPIB and androsterone (Atromid) are administered 
simultaneously, prolongation of the thrombin time* 
decrease of p l a t e l e t adhesiveness, and increased f i b r i -
no ly t i c a c t i v i t y was observed. CPIB has no inf luence on 
known components of the f i b r i n o l y t i c system when, given 
alone (Sweet ^ a i . , 1965). The apparent synerg i s t i c 
act ion of Atromid on the blood c l o t t i n g mechanism awaits 
c l a r i f i c a t i o n . The e f f e c t of Atromid on l i p i d metabolism 
and a the rosc le ros i s i s extensively discussed i n a number 
of papers (Symposium on Atromid, 1965). 
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Scope of This Thesis 
There i s ce r ta in r a t iona le to tbe f a c t that a 
compound act ive as an i n h i b i t o r of choles tero l biosyn-
thes i s may have u t i l i t y i n the treatment of hypercholes-
terolemia, a the rosc le ros i s and other a l l i e d d iseases . 
However, from the foregoing discussion on the i n h i b i t o r s 
of choles terol b iosynthes is , i t i s evident that none of 
the i n h i b i t o r s , so f a r known can be successfu l ly used 
without any side e f f e c t s , 3-Hydroxy-5-.methylglutauric acid 
(HMG), which in vivo a r i s e s from HMG-CoA by the ac t ion of 
HMG-CoA hydrolase (EC 3 .1 .2 .5 ) (Dekker e t 1958), i s 
an ant imetabol i te of mevalonic acid (Wright, 1957)'. 
Recently i t has been shown to competitively i n h i b i t the 
HMO-CoA reductase (EC 1.1 .1 .54) a c t i v i t y i n b a c t e r i a l a s 
well as r a t l i v e r preparations(Fimognari and Rodwell, 
1965). This may also explain the HKG i n h i b i t i o n of choles-
t e r o l synthesis from ace ta te (Rabinowitz and Gurin, 1954). 
Although HMG i s one of the i n h i b i t o r s of choles te ro l 
b iosynthes is , no attempts have so f a r been made to evaluate 
i t s possible hypocholesterolemic and hypolipemic ro l e . 
The present work i s directed to inves t iga te the hypo-
cholesterolemic and hypolipemic proper t ies of UMG in 
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jiorsial as i/ell as in hyperchoJesterolemic animals. This 
i s the topic of the chapter IV of t h i s t h e s i s . The 
e f f e c t of HMG a t c e l l u l a r l eve l ana i t s role i n the 
reversal of f a t t y l i v e r has been described in chapter V. 
A preliminary pharmacological screening of HMO i s the 
subject matter f o r chapter VI. The e f f e c t of d i e t a ry 
choles te ro l on hepatic HMS-^ oA hydrolase has been studied 
and discussed i n chapter VII. 
IV. U T R I T I O H A L S T U D I E S 
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e x p e r i m s n t a l 
Cfaeaicals - fhe following chemicals were obtained 
commercially and used without fu r the r pu r i f i ca t i on ! 
3-hydroxy-3^methylglutaric acid (HMO) (Mann ftesearch 
Laboratories and Signa Chemical Co., y .S .A, ) ; cholic 
acid and cholesterol (B. Merck, Germany); sodium 
cholate (Fluka, Switzerland). Hest of the chemicals 
used were of A.H. gr&de. 
Animals - Albino r a t s used in the present study were 
purchased from the Stock Colony of the Central Drug 
aesearch I n s t i t u t e , Lucknow (India) . 
Basal Diet Anidiet 'A* for r a t s was purchased from 
Chelsea Chemical Laboratories, Poona (India) as stock 
ra t ion and used as basal d ie t throughout the inves t iga t ion . 
The aaimals were allowed basal d ie t and water ad l ibi tum. 
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Quanti ta t ive Seteriaiaation of Tota l . Ester and free 
Cholesterol - The animals were aaaestheslzed with 
etherf hlood withdrawn by cardiac puncture and serum 
obtained* 
The method fo r serum choles terol determination 
i s e s sen t i a l ly that of Bloor ^ (1922). 1 ml of 
serum was added in to a dry 100 ml volumetric f l a s k con-
ta in ing 40 ml Bloor*s a lcohol-e ther mixture (3s1)* The 
contents of the f l a sk were constantly swirled to prevent 
clumping of the p r e c i p i t a t e . The f lask was stoppered 
immediately, shaken vigrously f o r two minutes and allowed 
to stand at room temperature f o r one hour* with occasional 
shaMng. The contents of the f l a sk were poured on to a 
Whatman No. 1 f i l t e r paper, immsdiately covering the 
funnel with a watch g lass . 10 ml of the Bloor*s a lcohol -
e ther f i l t r a t e was t ransfe red to a 50 ml dry beaker, eva-
porated sdmost to dryness on a steam t a t h , completing the 
t o t a l evaporation of the solvent at room temperature. 
About 3 Bil of anhydrous chloroform was added to the res idue , 
washing down the s ides of the beaker during the addi t ion . 
The contents were heated (bo i l ing s t r i c t l y avoided), 
decanted i n t o a 10 ml g lass stoppered standard f l a s k . 
The ext ract ion of the residue was repeated th r i ce with 
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3 ml port ion of chloroform and decanted i n t o the same 
f l a s k . The f l a sk was cooled to room temperatisre and 
volume was made up to 10 ml mark with chloroform« t r a n s -
fered in to a t e s t tube and corked. 2 ml of the colour 
reagent (10 pa r t s of d i s t i l l e d a c e t i c anh;fdride mixed 
with 1 par t of concentrated HgSO^) was added i n each tube. 
The tube was kept a t 25® i n dark f o r exact ly 30 minutes 
and the green color thus developed was read a ^ d n s t a 
reagent blank i n a Klett^-Suicmerson photoe lec t r ic c o l o r i -
meter using red or blue f i l t e r . Total cho les te ro l present 
i n the sample was calculated from a standard curve ( i l g s , 4 
and 5) , For reagent blank, a tube containing 10 ml of 
anhydrous chloroform and 2 ml of colour reagent was used, 
?or e s t e r choles terol another 10 ml of a lcohol-
e ther f i l t r a t e was taken i n a dry 50 ml beaker and 1 ml of 
t% digl tonin solut ion in alcohol added, mixed gently* eva-
porated to dryness as described previously. The residue 
was extracted twice with 5 ml petroleum e the r . The ether 
ex t rac t was decanted in to a dry beaker. The combined 
ex t r ac t s were evaporated to dryness and the residue was 
extracted with chloroform as described fo r t o t a l choles-
t e r o l , Qsing the standard curve» amount of e s t e r choles-
t e r o l was ca lcu la ted . The d i f fe rence between t o t a l and 
Fig. 4. Golorimetric est imation of choles terol 
(red So. 66 f i l t e r ) . See text for d e t a i l s . 
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e s t e r ohoXesteroI values gives the f r e e choles te ro l 
content of the serum. 
Liver choles terol was measured according to the 
modified method of Reinhold and Shiel as described by 
Hawk e t (1948). The l i v e r was cut i n to small p ieces , 
b lo t t ed and about 0 ,3 g weighed by random se lec t ion of 
p ieces . The weighed l i v e r was t ransfered to a mortar 
(containing about 10 g anhydrous sodium s u l f a t e } , mixed 
uniformly,dr ied in an oven a t 100° fo r 10 minutes, cooled 
and t ransfered quan t i t a t ive ly to Whatman ex t rac t ion 
thimble. The thimble was extracted with 100 ml of anhy-
drous chloroform in a Soxhlet ext rac t ion apparatus f o r 
exactly 2 hours. The chloroform ext rac t was allowed to 
cool and t ransfered quan t i t a t ive ly with r ins ings to a 
100 ml volumetric f l a s k , volume was made up to 100 ml 
mark, mixed and 10 ml a l iquot was analysed fo r t o t a l 
choles tero l as described above* 
Quant i ta t ive Betermination of Serum Phospholipids - The 
method i s o r ig ina l ly tha t of Zilversmit (1958), 0.2 ml of 
serum was accurately delivered i n cent r i fuge tubes contain* 
ing 3 ml of water . 3 ml of lOjS t r i ch lo roace t i c acid 
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(W/V) solut ion was added. The tubes were allowed to 
stand fo r few minutes and oentr i fuged for 30 minutes. 
The supernatant was decanted and the tubes were Inverted 
u n t i l p r ac t i ca l l y a l l the supernatant has been reffloved, 
1 ml of 60^ perch lor ic acid was added to each tube and 
digested on an e l e c t r i c digest ion un i t f o r 20-30 minutes. 
5 ml of d i s t i l l e d water was added to the c lear and colour-
l e s s solut ion a f t e r cooling. The standard tubes i n a 
volume of 5*8 ml contained 0.8 ml, 60% perchlor ic a c i d , 
0.02 or 0*04 mg The reagent blank had same amount 
of perchlor ic acid and 5 ml d i s t i l l e d water. 1 ml of 4% 
ammonium molybdate (W/V) and 1 ml, 1-amino-2-naphthol-4-' 
su l fonic acid reagent were added to sample, standard and 
reagent blank tubes. Af te r 20 minutes, the colour i n t e n -
s i t y was read i n a Klett-Summerson photoelec t r ic c o l o r i -
meter (red f i l t e r ) . The amount of phospholipid was c a l -
culated as given below: 
Absorbance of unknown „ _„ i-nt ^ t „ »nn — 
Absorbance of standard * Standard x ^ x 100 « 
mg of Phospholipid *PVtOO ml. 
Phospholipid (mg %) a Phospholipid x 25. 
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Quanti ta t ive Setermlnation of Serum Total E s t e r i f i e d 
Patty Acids - Measurement of t o t a l e s t e r i f i e d f a t t y 
acids and t r i g lyce r ide s i s based upon the method of 
Heinhold et a l . (1963). 5 ml of the Bloor*s a lcohol -
e ther f i l t r a t e of serum (as described previously f o r 
cho les te ro l ) was t ransfe red to t e s t tubes. Standard 
tubes contained and 1.0 jumoles of cho les te ry l 
ace ta te in 3 ml of Bloor*s alcohol-ether mixture. An 
addi t iona l tube containing ^ ml of a lcohol -e ther mixture 
•waB used as reagent blank. To sample, standard and blank 
tubes were added 0 .3 ml of 2 K hydroxylamine hydrochloride 
solution^ Af te r mixing, 0 .5 inl of 3.5 NaOH solut ion 
were added and mixed, t he tubes were stoppered and allowed 
to stand a t room temperature for 20 minutes to enable the 
hydroxylamine hydrochloride to r eac t . 0.6 ml of 4 H HCl 
was added, followed by the addi t ion of 0 .5 ml of 0.37 M 
f e r r i c perchlorate so lu t ion . After thorough mixing, the 
tubes were placed i n a water bath a t 25® fo r exact ly 5 
minutes. Using a green f i l t e r , the hydroxsuaatc colour 
was read i n a Klett-Suxomerson photoe lec t r ic colorimeter . 
U t i l i z i n g the standard equivalent! 
meq t o t a l e s t e r i f i e d f a t t y ac id /1 a umoles of choles teryl 
^ Absorbance of tinknown _ 
ace ta te x Absorbance of standard * 3 ' 
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Quant i ta t ive Betermination of Sertm Tr ig lycer ides - The 
d i f fe rence between t o t a l e s t e r i f i e d f a t t y acids (TEFA) 
and phospholipid f a t t y acid (H'A) plus f a t t y acids e s t e r i -
f i e d in the choles tero l (Ci'A) givesj 
t r i g l y c e r i d e f a t t y acid meq/l TEFA - (EFA + CPA) 
PFA == l i p i d l O x 1.8 ^ 0^58 ^^^^^ .p, 
where l i p i d i s expressed as mg »P'/100 ml» and 1,8 
i s the average molar r a t i o of f a t t y acid to 'P*. 
CFA « 0.29 a 0.0075EC 
^here the e s t e r i f i e d choles terol (EC) i s expressed i n 
mg/lOO ml; 0.29 i s an experimentally derived f ac to r fo r 
cor rec t ing f o r the incomplete reac t ion of higher f a t t y 
acids e s t e r i f i e d with choles terol under the prescribed 
experimental condit ions. 
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a s s u L I S 
Effec t of Oral Adiainistration of HMG on Serma aad Liver 
Cholesterol of HorfflOcholesterolemic Rata - Forty e i | ^ t 
young male Albino r a t s , w e i ^ n g about 50 g and each 
group containing s ix animals, were se lec ted . Group I was 
kept as control and fed on basal d i e t . In addi t ion to 
t h i s d i e t , groups I I , I I I and IV received o r a l l y , varying 
doses of HMG i n water , as ind ica ted , f o r seven or four teen 
days. At the end of each treatment, the r a t s were weighed, 
and the serum obtained. The l i v e r s were a lso removed, 
b lo t ted and weighed. Total serum and l i v e r choles te ro l 
was determined. 
The oral feeding of HMG causes s i gn i f i c an t lowering 
of t o t a l serum choles terol l e v e l s , without in f luenc ing the 
l i v e r choles terol content . The r e s u l t s are summarized in 
Table I . 
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d i s t i l l e d water. On seventh day, the r a t s were weighed, 
serum and l i v e r to t a l choles terol was determined, 
the i n i t i a l weight r e f e r s to the average weight 
of the r a t s a t the s t a r t of the experiment. The f i n a l 
weight r e f e r s to the average weight of the r a t s before 
s a c r i f i c e . The average d ie t intake of the control and 
experimental group was 10.7 g /day/ ra t and 10*3 g /day/ ra t 
respec t ive ly . In t r ape r i tonea l adminis t rat ion of HMQ a lso 
decl ines serum cho les t e ro l . No e f f e c t was observed on 
l i v e r cholesterol l e v e l s . The data are presented in 
Table I I . 
E f fec t of HHQ on Serum and Idver Cholesterol of 
Cholesteroleaic Rats - Seventy three young male Albino 
r a t s weighing about 100 g were maintained on basal d i e t . 
For tyf ive r a t s were dai ly given 10 mg choles tero l f o r 
28 days by in tubat ion as described (Siddiqi e t , 1964). 
The serum choles terol l e v e l of such r a t s was not s i g n i f i » 
cant ly elevated (132 h^  2 mg %) as compared to control r a t s 
(119 + 9 mg After t h i s period the r a t s were caged 
separa te ly in groups of three and four each f o r choles-
terolemic group and HMQ - fed group respec t ive ly . The 
T a b 1 e « I I 
E f fec t of In t r ape r i tonea l Administratioii of HMQ 
on Serum Cholesterol of Hormocholesterolemlc Rata 
Group 






choles tero l 
im 
Control 48 + 2 60 + 12 125 t 4 
Bxperimental 51 1 8 3 + 3 91 + 2® 
2 
a 
Difference as compared to control group s t a t i s t i c a l l y 
s i g n i f i c a n t p -< 0.001 • 
3 
cholesteroleiBic control groups did not receive HMQ whereas 
the r a t s i n HMO-fed group were o ra l ly given 6,5 og HWH/Kg/ 
day In d i e t i l l e d water fo r varying per iods. Twenty eight 
r a t s i n groups of four each ne i the r received choles te ro l 
nor and served as control throughout the inves t iga t ion 
(control group). At the indicated period of treatment, 
the r a t s were w e i r e d , t o t a l serum and l i v e r choles te ro l 
detersdned. 
The HMS intubat ion to cholesterolemic r a t s e f f e c -
t ive ly lowers t o t a l serum choles te ro l levels* However, 
the l i v e r choles te ro l content was not a f f e c t e d by HMGt 
feeding. The r e s u l t s a re suioooarieed i n Table I I I . 
E f f ec t of 8HG and Cholesterol plus HMQ Feeding on Serum 
Cholesterol of Hypercholesterolemic Bats - Young male 
Albino r a t s weighing about 100 g were maintained f o r two 
weeks on an experimental d ie t (basal d i e t containing 2% 
hydrogenated vegetable o i l | 20 mg choles te ro l and 10% mg 
sodium cholate as homogeneous water suspension, by i n t u -
ba t ion) In order to produce hypercholesterolemic condi-
t i ons . The serum choles tero l l eve l of such r a t s was 
found to be s i ^ i f i c a n t l y elevated (192 • 19 mg 
p <10.001) as compared to r a t s kept on basal d i e t only 
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I a b 1 e ^ I I I 
Ef fec t of HHG on 8enim Cholesterol of Cholesterolemic 











1st 107 t 9 131 t 3 67 + 7^ 
2nd 116 1 ? 1 H ^ 8 69 t 
107 ± 11 111 + 5 77 i 9® 
4th 105 t 9 103 + 9 65 t 
5th 112 ± 8 108 + 4 84 + 5 
® Difference as compared to eholesterolemic group 
s t a t i s t i c a l l y s i g n i f i c a n t p-C 0.001 j ^ p < 0.01 j 
® p ^ 0 .02. 
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(118 3 mg the r a t s were then divided i n to groups 
of f ive each. The eholes te ro l - fed and choles te ro l p lus 
HM6<*fed groups continued receiving experimental d i e t . 
However, i n add i t ion , the l a t t e r group received 50 mg 
HM6/Kg/day i n d i s t i l l e d water. After two weeks the 
experimental d i e t was replaced by hasal d i e t f o r hyper-
cholesterolemic control groups and HMO-fed groups a l s o . 
The l a t t e r received 50 mg HKS/Kg/day i n water. At vary-
ing periods of liMQ treatment, as ind ica ted , the serum 
choles te ro l was determined. 
I t i s evident that s i g n i f i c a n t lowering of 
choles te ro l takes place in HMO-fed groups as compared 
to p a r a l l e l hyperchoiesterolemic control groups. I t was 
a l so observed tha t combined feeding of choles tero l along 
with HMO also s i g n i f i c a n t l y decl ines the serum choles-
t e ro l l eve l s as compared to cho les te ro l - fed groups. The 
r e s u l t s are presented in Table IV. 
Ef fec t of HMQ and Cholesterol plus HMQ feeding on Liver 
Cholesterol of Hypercholesterolemic Bats - The l i v e r 
choles te ro l of the same animals as described i n Table IV 
was determined. The l i v e r choles terol of hypercholes-
terolemic r a t s , a f t e r two weeks of experimental d i e t , was 
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T a b 1 e IV 
E f f e c t of tfi^ Q and choles te ro l plus H^«3 Feeding on 
Serum Cholesterol of Bypercfaolesterolemio Bats 
(average • S.E.) 
tSJeatment Total Cholesterol content (m^ 
(day) Cholesterol- Cholesterol ijypercholes- HMO-fed 
fed + HMG-fed terolemic 
control 
group group group group 
1st 207 t 10 139 200 4- 6 133 + 
2nd 203 mm 4 129 + 181 + mm 4 138 
.a 
3rd 208 + 2 172 t 192 + 6 165 + 
.a 
4th - - 181 5 148 + 
5th 211 * 14 167 + 158 5 162 + 4 
6th * 139 5 137 4- 7 
Difference as compared to respect ive control group 
s t a t i s t i c a l l y s i g n i f i c a n t p C 0.0011 ^ p « 0.01. 
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s i g n i f i c a n t l y high (1183 + 36 mg p < 0.001) as 
compared to r a t s maintained on basal d i e t only (523 * 29 
m 
As ahovn i n Table V» s i g n i f i c a n t lowering of 
l i v e r cho les te ro l occurs i n HMG-fed groups as compared 
to hypercholesterolemic cont ro l groups. The combined 
feeding of choles te ro l along with HMO, a lso s i g n i f i c a n t l y 
decreases the l i v e r cho les te ro l l eve l s as compared to 
cho les te ro l - fed groups. 
E f fec t of In t r ape r i tonea l I n j ec t i on of HMG on Serum and 
Idver Cholesterol of Hypercholesterolemic Rats - toung 
male Albino r a t s , weighing about 80 g were kept on ^ 
experimental d i e t (basal d ie t containing cho le s t e ro l , 
chol ic acid and 3% hydrogenated vegetable o i l ) f o r 25 
days i n order to produce hypercholesterolemia. Af ter t h i s 
period the experimental d i e t was replaced by basal d i e t 
and r a t s were divided i n t o nine groups separately in groups 
of f i v e each. From the weight of d i e t consumption, i t 
was calculated that each r a t received 220 mg cho les t e ro l , 
110 mg chol ic acid mid 550 mg hydrogenated vegetable o i l 
per day. The t o t a l serum and l i v e r choles te ro l l e v e l , 
of normal untreated r a t s kept on basal d i e t only, was 
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T a b I e » V 
Ef fec t of HMg and Cholesterol plus HMO Feeding on Liver 
Cholesterol of Hypercfaolesterolemic Rats (average + S .E . ) 
HMG 
treatment — — 
(day) Choles tero l -
fed 
group 
Cholesterol Hypercholes- HMG-fed 
•f HMG-fed terolemlc 
control 
group group group 
l e t 1167 t 52 994 + 6® 1376 + 3 8 912 • 33^ 
2nd 1366 t 31 789 + 47^ 1084 ± 42 633 t 11^ 
3rd 1279 t 25 958 1 52^ 934 + 40 586 + 28^ 
4th 1258 • 40 962 + 34^ 1078 + 40 656 ± 8^ 
5 th 1566 t 63 1004 * 24^ 896 + 23 775 + 36® 
6th 608 * 18 626 I- 11 
Difference as compared to respect ive control group 
s t a t i s t i c a l l y s i g n i f i c a n t p « 0.01} ^ p < 0.001} ® p<^0.05. 
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103 + 6 mg ^ and 617 + 31 Jag ^ respec t ive ly , fiats i n 
iaiO-fed group received 20 mg, HMO/Kg in t r ape r i t onea l l y 
i n d i s t i l l e d water, whereas animals i n bypercholestero-
lemic control group were given one ml d i s t i l l e d water 
. ( i . p . ) . The animals were anaesthesized with e the r , 
d issected and blood withdrawn by cardiac puncture a t 0, 
89 16 and 24 hours. The l i v e r s were also removed, 
b lo t ted and weighed, f o r the l a s t group the HMG dose 
was repeated at 24 and 48 hours, blood and l i v e r s c o l l e c -
ted at the end of 72 hours. The choles terol content of 
serum and l i v e r was determined. 
In t r ape r i tonea l i n j e c t i o n of HHS i s a l so e f f e c t i v e 
in lowering both serum and l i v e r choles tero l content of 
hypercholesterolemic r a t s . Tables VIt VII summarizes the 
r e s u l t s . The inf luence of subsequent doses repeated a t 
24 hours i n t e r v a l s seems to be addi t ive (Fig. 6) . 
jSffect of HMO on Serum Lipids of Hormocholesterolemlc 
fiats - Two groups of young meCLe Albino r a t s , weighing 
about 110 g and each group containing f i v e animals were 
caged separa te ly . One group was kept a s control and fed 
on basal d ie t and received one ml d i s t i l l e d water ( i . p , ) . 
In addi t ion to the basal d i e t , animals i n the second 
60 
Fig, 6» E f fec t of HMG on serum and l i v e r 
choles terol of hypercholesterolemlc r a t s a t 
d i f f e r e n t time i n t e r v a l s . See text for d e t a i l s . 
Serum Cholesterol ( m g i ' ) 
H 
3 
X o c -i 
CO 
Liver Cholesterol ( m g ^ ) 
61 
T a b 1 e ^ VI 
Effect of Intraperitoneal Infection of HMG on Serum 
GfaoXesteroi of HypercholesteroXemic f tats (average + S . S . ) 
Qroup Total serum cholesterol content (mg^) 
0 fers. 8 h r s . 16 h r s . 24 b r s , 72 h r s . 
Hypercholes- 863 4 6 583 + t4 4 1 3 + 1 6 450 + 7 2 9 0 + 1 3 
terolemic 
cont ro l 
group 
HHG-fed « 5 4 0 + 1 8 335 + 18® 346 + 24^ 249 + 10® 
group 
^ Difference as compared to hypercholesteroXemic con t ro l 
group s t a t i s t i c a l l y s i g n i f i c a n t p « 0.01 f ^ p<: 0.001 j 
® p ^ 0 .01 . 
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Y a b I e « VII 
Ef fec t of In t r ape r i tonea l I n j ec t i on of IMQ on Liver 
Cholesterol of Hypercholesterolemlc Hats (average • S .E . ) 
Q^ Qy^ p Total Liver Cholesterol content (mg 
0 hrs« 8 h r s . 16 h r s , 24 h r s . 72 h r s . 
Hypercholes- 15677+205 14791+210 13460+210 12240+550 10665+140 
terolemic - - - -
control 
group 
HMQ-fed • 14334+280 13015+110 8997+150® 9101+250® 
group 
® Difference as compared with hypercholesterolemic 
control group s t a t i s t i c a l l y s i gn i f i c an t p < 0.001. 
G3 
group were given i n t r a p e r i t o n e a l i n j e c t i o n s of 20 mg 
HMG/Kg/day i n d i s t i l l e d water f o r three o r s i x days* At 
the end of treatment serum l i p i d s were determined. The 
r e s u l t s of t h i s experiment are given i n Tahle VIZI. I t 
i s evident tha t HH0 admin is t ra t ion to normal r a t s f o r 
3 or 6 days s i g n i f i c a n t l y depresses the t o t a l c h o l e s t e r o l , 
e s t e r i f i e d cho le s t e ro l t o t a l e s t e r i f i e d f a t t y acid and 
t r i g l y c e r i d e l e v e l s . However, there i s no s i ^ i i f i c a n t 
e f f e c t on f r e e cho les te ro l and phospholipid l e v e l s . The 
C/P r a t i o i s i n s i g n i f i c a n t l y lowered. 
Effect of Cholesterol plus HI^ G Feeding on Serum Lipids 
of Hyperlipemic Rats • Five animals weighing about 
100 g were fed on basal d i e t containing 2% c h o l e s t e r o l , 
chol ic acid and hydrogenated vegetable o i l (choles-
t e r o l - f e d group). In add i t ion to the above f a t - r i c h 
cho les te ro l d i e t , o ther f i v e animals ( cho le s t e ro l 4- HMG-
fed group) were given 20 mg HM6/£g/day i n t r a p e r i t o n e a l l y 
i n water. The cho le s t e ro l - f ed group' received i n j e c t i o n s 
of ( U s t i l l e d water (t mi) . Af te r 25 days, serum l i p i d s 
were es t imated. The animals were da i ly w e i r e d and no 
s i g n i f i c a n t d i f f e rence was noted between the two groups. 
There was no s ignif iceui t d i f f e r e n c e in d i e t a ry in take of 
fj'i 
T a b l e s VIII 
E f fec t of HMG on Serum Lipids of Hormocholesteroleiaic 
Rats (average + S.E.) 
Basal d i e t Basal d ie t • HMG 
3 days 6 days 3 days 6 days 
Total cho le s t e ro l , 
mg % 
70 I 2 100 + 2 60 + 4® 83 + 2^ 
Ester cho les t e ro l , 
mg % 
50 + 2 74 t 2 40 + 4^ 60 + 
Free cho le s t e ro l , 
mg % 
20 + 3 26 + 1 2 0 + 3 23 + 1 
Total e s t e r i f i e d 
f a t t y ac ids , 
meq/1 
6 t 0.36 5.2+ 0.28 5.1+ 0.44® 4.1+ O.U*' 
Phospholipids, 
mg % 
186^ 14 153 + 5 187 + 19 140 + 8 
Tr ig lycer ides , 
meq/l 
0.17 1.1 4-mm 0.16 0.53+ 0.04^ 0.4+ 0.14® 
^ Difference as compared to p a r a l l e l basal d ie t control 
s t a t i s t i c a l l y s i g n i f i c a n t p < 0.05? ^ p<C 0.001 j 
® p < 0 . 0 1 . 
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cholesterol-fed. (11.5 + 0*3 g / ra t /day) and choles tero l 
plus HMO-fed (10.3 t 2 .3 g / r a t / day ) groups. I t i s 
i n t e r e s t i n g to mention that there was a s i g n i f i c a n t 
decrease in the average w e i ^ t of l i v e r s of the choles-
t e r o l - f e d group in comparison to choles terol plus HM6-
fed group (5.925 t 0*36 and 7.104 + 0.024 respec t ive ly ; 
p < 0 . 0 5 ) . 
The data in Table IX show that ifi^ G treatment 
causes a s i ^ i f i c a n t decline in the l eve l s of d i f f e r e n t 
l i p i d s of hyperl ipei^c r a t s as compared to p a r a l l e l 
cho les te ro l - fed group. However, the decrease in t o t a l 
and es t e r choles terol i s s t a t i s t i c a l l y i n s i g n i f i c a n t and 
C/P r a t i o remains elevated, probably due to continued 
feeding of cho les te ro l . Similar to Table VIII , there i s 
no e f f e c t of ffi4G on f r e e cho les te ro l . 
E f fec t of HMG on Serum Lipids of Hyperlipemic Rats - Ten 
male r a t s w e i r i n g about 100 g were maintained on f a t -
r i ch choles terol d ie t as described above, for a period of 
25 days and then divided i n to two groups of f ive each. 
The hyperlipemlc control group was given basal d ie t only 
whereas the HMG-fed group in addit ion to t h i s d ie t 
received i n t e rpe r i t onea l i n f ec t i ons of 20 mg HMO/Kg/day 
6 
T a b 1 e - IX 
E f f e c t of Choles terol plus HHG Feeding on Serum 
Lipids of flyperlipemiQ Rats (average + S . S . ) 
Choles te ro l - fed Choles terol 
HMG-fed 
group group 
Total c h o l e s t e r o l , 855 + 35 fflg ^ 
Es ter c h o l e s t e r o l , 673 26 
mg % 
Free c h o l e s t e r o l , 183 + 20 
mg ^ 
Total e s t e r i f i e d 2 7 + 3 
f a t t y a c i d f , 
meq/l 
Phospholipids, 341 + 27 
mg % 
Tr ig lyce r ides , 1 5 + 2 
meq/1 
780 I 25 
596 + 44 
184 i 6 
21 t 2^ 
256 + 23* 
11.5 t 
Difference a s compared to cho le s t e ro l - f ed group 
s t a t i s t i c a l l y s i g n i f i c a n t p < 0 .05j ^ P < 0 .02 . 
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i n water. The p a r a l l e l control group received i n j e c t i o n s 
/ 
of d i s t i l l e d water (1 mi). Af ter s i x days serum l i p i d s 
were estimated. 
I t i s apparent from the data shown i n Table X 
tha t although f a t - r i c h choles terol d i e t was subs t i tu ted 
by the basal d i e t , the animals i n both the groups were 
s t i l l hyperlipemic. However, as compared to control 
group, the C/P r a t i o was s i g n i f i c a n t l y lowered i n HMG-
fed group (Cf. Table IX). The decrease i n various types 
of serum l i p i d contents was s t a t i s t i c a l l y s i g n i f i c a n t . 
Again no e f f e c t of HMG was observed on f r§e choles te ro l 
l e v e l s . 
8 
T a b I e > X 
Ef fec t of HM6 on Serum Lipids of Hyperlipemic Bats 
{average + S .E. ) 
Hyperlipemic Control BMG-fed 
group group 
Total cho les te ro l , 1 6 1 + 1 0 104 • 
mg ^ 
Ester cho les t e ro l , 125 + 12 67 + 4®" 
mg ^ 
Free cho les te ro l , 37 ^ 4 3 7 + 2 
mg ^ 
Total e s t e r i f i e d 9 + 0,28 6 + 0 .5 
f a t t y ac ids , 
meq/1 
Phospholipids, 1 8 2 + 7 1 4 8 + 8 ^ 
mg % 
Triglycerides,, 4 + 0.28 2 + 0,39' 
meq/l 
C/P r a t i o 0.885 + ^'004 0.675 + 0,005® 
^ Difference as compared to hyperlipemic control animals 
s t a t i s t i c a l l y s i g n i f i c a n t p < 0 . 0 1 | ^ p = 0.01$ 




P I S C 0 S S I 0 N 
Buring the past several decades, i t has been 
rea l ized that a r t e r i o s c l e r o s i s and other re la ted diseases 
are associated with derangements in l i p i d metabolism. The 
demonstration by yindaus (1910) and Schoenheimer (1926), 
that choles terol accumulates in a the rosc le ro t i c aor tas and 
tha t hypercholesterolemia and a therosc le ros i s can be 
induced i n rabbi t s by feeding choles terol (Anitschkow and 
Chalatow, 1913), has resu l ted in the amassment of vast 
l i t e r a t u r e concerning the ro le of cho les te ro l in the 
genesis of human a the rosc l e ros i s . 
Considering the various f a c t o r s known to be 
involved i n choles terol metabolism, i t has been suggested 
that control of serum and possibly t i s sue choles tero l 
l e v e l s might be achieved byj ( i ) s t imulat ion of i t s des-
t ruc t ion and excret ion ( i i ) i nh ib i t i on of i t s absorption 
and reabsorption or ( i i i ) i nh ib i t i on of endogenous 
synthes is . A number of drugs, have been shown to i n t e r -
f e r e with choles te ro l synthesis and are belived to exert 
t h e i r hypocholesterolemic e f f e c t v ia the l a s t mechanism. 
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During recent years the involvement of two other 
c l a s s of l i p i d s , t r i g l y c e r i d e s and phospholipids, i n the 
pathogenesis of cardiovascular disease has been suggested 
by several i n v e s t i g a t o r s . In §ome cases endogenous syn-
thes i s of t r ig lyce r ides makes a ma^or contr ibut ion to the 
hyperlipemia in associa t ion with hypercholesterolemia* 
I t i s evident from the pathway shown i n Fig. 1 
that several of the precursors of MVA are involved i n 
other important metabolic reac t ions . Acetyl CoA i s o x i -
dized v i a the Krebs cycle , or i s converted to malonyl 
CoA as indicated by reac t ion 3f and subsequently to f a t t y 
ac ids , t r i g l y c e r i d e s , and phospholipids. HMG-CoA was 
shown to be an obligatory intermediate i n the synthesis 
of Hm (Dekker ^ t , 1958) and ace toace t ic acid (Lynen 
£t , 1958). Therefore any i n h i b i t o r of choles te ro l 
b iosynthesis ac t ing p r io r to HMG-CoA can not be success* 
f u l l y used as hypocholesterolemic agent because i t would 
a lso e f f e c t other important metabolic reac t ions of the 
body. Gould (1960) has suggested that the conversion of 
HMO>CoA to MVA would be the idea l s i t e to regula te 
choles te ro l synthesis s ince a block a t t h i s s i t e would 
not i n t e r f e r e with the other metabolic processes j u s t 
discussed. Miglcovsky (1962) showed tha t the focal point 
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fo r na tu ra l control of choles terol synthes is may be a t 
t h i s l e v e l . 
In viyo HMG i s synthesized i r r e v e r s i b l y from HMG-
CoA by the act ion of HMG-CoA hydrolase. Although Burch 
e t a l . (1964) have demonstrated the ac t iva t ion of HMG 
v ia a CoA t ransferase i n r a t kidney mitochondria^ no 
conclusive evidence i s yet avai lable to subs tan t i a t e the 
presence of a kinase or CoA t ransferase system i n l i v e r 
which i s the chief s i t e of cholesterol biosynthesis 
(Morris and Chaikoff, 1959). 
Since HMG has been shown to act as an i n h i b i t o r 
of choles te ro l biosynthesis between HMG«<CoA and MVA 
(Rabinowitz and Gurin, 1954} Fimognari and Rodwell, 1965) 
and the pos s ib i l i t y that the t rue i n h i b i t o r of HMG->CoA 
reductase i s other thaai f r e e choles terol (Linn, 1967), 
i t s feeding would be expected to lower the choles tero l 
l e v e l s . 
As evident from the data presented i n Tables I , 
I I and VIII , HMG i s not only e n a b l e of decreasing t o t a l 
serum choles te ro l but a lso decreases e s t e r cho les t e ro l , 
t o t a l e s t e r i f i e d f a t t y acids and t r i g l y c e r i d e s of nor -
mocholesterolemic animals. The compound i s e f f e c t i v e 
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both o ra l ly and i n t r a p e r i t o n e a l l y , the l a t t e r mode of 
administrat ion appears more e f f e c t i v e ( fab le I I ) . I t i s 
i n t e r e s t i n g to note tha t i n normal r a t s , l e v e l s of serum 
f r e e choles terol and phospholipids sure not s i g n i f i c a n t l y 
a f f ec t ed by HMO adminis t ra t ion . The compound d i s t i n c t l y 
lowers the serum choles terol content of cholesterolemic 
animals (Table I I I ) but f a i l s to inf luence the l i v e r choles-
t e ro l content of normal as well as cholesterolemic r a t s . 
HM6 a lso blocked the experimentally induced hyper-
cholesterolemia both i n serum and l i v e r (Tables IV, ¥ , VI 
and V I I I t i s readi ly absorbed when administex^d o ra l ly 
or i ia t raper i toneal ly to the r a t s . Lowering of serum and 
l i v e r choles te ro l commences within 12 hours of HMO adminis-
t r a t i o n . The e f f e c t i s maxiimim between 16 to 24 hours. 
The inf luence of subsequent doses repeated a t 24 hours 
i n t e r v a l s seems to be addi t ive ( f i g . 6)« 
HHG i s also capable of decreasing the serum e s t e r 
cho le s t e ro l , t o t a l e s t e r i f i e d f a t t y a c i d s , phospholipids 
and t r i g lyce r ides content of hyperlipemic r a t s (Tables IX 
and X). The animals receiving f a t - r i c h choles te ro l d ie t 
responded to EH6 treatment , showed reduct ion i n t o t a l cho-
l e s t e r o l , e s t e r cho les t e ro l , t o t a l e s t e r i f i e d f a t t y ac ids , 
phospholipids and t r i g lyce r ide s to the extent of 1036, 12Sl,23?J» 
25% and 23^ respect ively (Table IX). Kowever, the t o t a l and 
e s t e r choles terol are i n s i g n i f i c a n t l y lowered and C/P r a t i o 
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remains e levated, because choles tero l i s continuously 
being f ed . Phospholipids and t r i g lyce r ides are s i g n i -
f i c a n t l y depressed. I t i s qui te l i k e l y that amount of 
UWa in;iected I s not s u f f i c i e n t enough to s i gn i f i c an t l y 
lower the t o t a l and e s t e r choles terol and the C/P r a t i o . 
Nevertheless^ treatment with HHG together with f a t - r i c h 
cho les te ro l d i e t did check the r i s e of t a r l o u s l i p i d s 
to a considerable extent , on withdrawl of cho les te ro l 
d ie t (Table X), the average C/P r a t i o s i g n i f i c a n t l y 
decreased to the extent of i s t e r i f i e d choles terol 
l e v e l s are also cor re la ted to serum phospholipids which 
changed from 0.68 to 0.456 (or p < 0 . 0 1 ) . I t i s 
Important to note that UMG causes maxifflum decrease i n 
e s t e r choles terol and t r ig lycer ide l e v e l s (46?S and 50% 
r e spec t ive ly ) . Evidently there was no e f f e c t of HMG on 
the f r e e choles terol content of hyperlipemic animals. 
The a b i l i t y of HMG to lower t o t a l , e s t e r cho les -
t e r o l , t o t a l e s t e r i f i e d f a t t y ac ids , phospholipids and 
t r i g lyce r ides i s of specia l importance, s ince e levat ions 
i n these biochemical parameters have been reported as 
cha rao te r s t i c of ind iv idua ls s u f f e r i n g from coronary 
hear t disease (Gert ler and white, 1954) and recent ly 
grea te r a t t en t ion has been placed on the need f o r the 
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evaluat ion of serum t r i g lyce r ides than that of serum 
choles te ro l (Albriak £ t , 1961). I t i s important to 
note that HMG causes maximum reduction of t r i g lyce r ide s 
i n normal as 'we l l as cholesterol<-fed r a t s (Table VIII» 
IX and X>. 
Furthermore, i t i s i n t e r e s t i n g to emphasize tha t 
throughout these s tud ies no weight l o s s , no s i g n i f i c a n t 
d i f f e rence in the d i e t consumption and no v i s i b l e change 
i n behaviour of HMQ^treated animals as compared to p a r a l l e l 
non-t reated animals was observed. The observation, tha t 
HMG i s well absorbed and to le ra ted by animals, i s not 
su rp r i s ing because HHG i s a na tura l metabolite synthesized 
i n vivo from HMG-CoA by the act ion of hepatic HMG-CoA 
hydrolase. 
Many compounds i n i t i a l l y known to i n l d b i t the 
choles terol biosynthesis were l a t e r on shown e f f e c t i v e 
hypocholesterolemic and hypolipemic eigents (Holmes, 1964)* 
Although var ious workers had implicated HMG as the i n h i b i -
to r of choles te ro l biosynthesis a t HMG-CoA reductase s tep , 
the present work i s the f i r s t attempt to demonstrate the 
hypocholesterolemic act ions of HMG. I t i s well known 
tha t any act ion of an i nh ib i t o r of cho les te ro l synthes is 
i l g , 7. Normal a rch i t ec tu re of r a t l i v e r 
(H & EX 288). Separation bonds i n between c e l l s 
are a r t i f a c t s . See text f o r d e t a i l s . 
Fig. 8* Advanced f a t t y metamorphosis as evidenced 
by i s l ands of empty looking l i v e r c e l l s (li & EX .288), 
Broad empty bands are a r t i f a c t s produced by undue 
hardening during f i x a t i o n . See text fo r d e t a i l s . 
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would be superimposed on the b iosynthet ic regulatory 
mechanisms, which wi l l necessar i ly induce changes along 
whole of the react ion sequence involving choles terol 
formation and catabolism. The mechanism of act ion of 
HMG appears to be primarily due to i t s i n t e r f e r ence 
with choles terol biosynthesis between HMG«>CoA and MVA« 
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S X P S R I M E N X A L 
Studies made i n the previous sect ion indicated 
tha t HMO i s a very potent hypocholesterolemic and hypo-
Xipemic agent. In order to ru le out the toxic e f f e c t of 
laia a t c e l l u l a r l e v e l , i t became per t inen t to i n v e s t i -
gate the e f f e c t of HMO on d i f f e r e n t t i s s u e s and organs 
a t microscopic l e v e l . I t i s well known that feeding of 
f a t - r i c h choles terol d i e t not only r e s u l t s i n hypercholes-
terolemia and hyperlipemia i n r a t s but also produces f a t t y 
l i v e r s . Therefore i t was planned to study the e f f e c t i v e -
ness of ifilO in the reversal of f a t t y i n f i l t r a t i o n of r a t 
l i v e r s produced a t microscopic l e v e l . 
Mater ia ls and Methods - Standard h i s to log i ca l methods 
were used i n preparat ion of t i s sue s l i d e s <Clayden, 1962). 
The experimental condit ions and n u t r i t i o n a l s t a tu s of r a t s 
used have been described under r e s u l t s . 
V. H I S T O P A T H O L O G I C A I . S f U D I S S 
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RESULTS 
Effec t of HMG on M f f e r e n t Tissttes of Honaocholestero*-
lemic Rats - Noriaal f i ve young male Albino r a t s weighing 
about 100 g» were o ra l ly given 20 mg {{Ha/Kg/day fo r 4 weeks. 
Liver , hea r t , Jsidney, adrenals , spleen, ao r t a , bra in and 
lungs of HHO-treated and untreated animals were taken out 
and preserved i n 10^ formalin. His to logica l study was 
car r ied out by conventional p a r a f f i n embedding. Sections 
of four micron thickness were cut on a rotary microtome, 
s ta ined with haematoxylin and eosin. On microscopical 
examination the c e l l u l a r a rch i t ec tu re of HMO-treated 
t i s s u e s was normal and s imi lar to untreated animals. 
These s tud ies showed that HMO treatment did not 
induce any toxic or abnormal changes a t the microscopic 
l eve l of the t i s sues examined. 
Ef fec t of tgiO on Fatty IJ^vers of Hypercholesterolemic Hats -
The l i v e r s of r a t s , used fo r Table V, were teJcen out £uid 
preserved i n 10^ formalin. The his topathologic s tud ies 
were carr ied out by conventional p a r a f f i n embedding a f t e r 
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dehydration of the t i s sue i n alcohol . Sections of four 
micron thickness were cut on a ro ta ry isicrotoaie, s ta ined 
with the rout ine haematoxylin and eosin s t a i n . 
A his topathological study on l i v e r s from normal 
r a t s (525 ± 29 m ^ ) , revealed the c e l l u l a r a rch i t ec tu re 
of the normal l i v e r . The parenchymatous c e l l s are normal 
( H g . ?>• When compared to the hypercholesterolemic l i v e r , 
(l'l83 j; 36 mg^), the sect ion shows i n t r a c e l l u l a r f a t t y 
deposi ts as evidenced by areas of empty looking c e l l s 
(ilg« 8 ) . At frequent places whole l i v e r t i s sue was found 
converted in to i s lands of f a t c e i l s . 
Histological s tud ies were then extended towards the 
l i v e r s of HMO-treated hypercholesterolemic r a t s . Figures 
9 to 11 show sect ions of l i v e r s of hypercholesterolemic 
control r a t s and HMG-fed r a t s on 4th and 6th day of HMQ 
treatment . I t i s observed that on 4th day the l i v e r c e l l s 
of hypercholesterolemic control group animals, were s t i l l 
foamy ( i l g . 9) where as those of HMG-fed r a t s did not show 
any foamy appearance ( ^ g . tO), though an increase i n 
r e t i cu loendo the l i a l c e l l s (fiS c e l l s ) was seen i n both the 
groups as compared to normal (Fig. 7) . I t i s i n t e r e s t i n g 
to mention tha t choles terol content of l i v e r s of HMO-treated 
Fig, 7. Hormal a rch i t ec tu re of r a t l i v e r 
(H & £X 288). Separation bonds i n between c e l l s 
are a r t i f a c t s . See tex t f o r d e t a i l s . 
Fig, 8 . Advanced f a t t y metamorphosis as evidenced 
by i s l ands of eiopty looMng l i v e r c e l l s (H & EX 288), 
Broad empty bands are a r t i f a c t s produced by undue 
hardening during f i x a t i o n . See text fo r d e t a i l s . 

H g . 9* Moderate degree of f a t t y metaffiorphosls 
(H & EX 288), See text f o r d e t a i l s . 
Fig. 10. Hormal l i v e r parenchyma with increase 
i n re t i cu loendothe l ia l c e l l s (H & EX 288), See 
text f o r d e t a i l s . 
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r a t s touched the normal l eve l (636 * 8 mg^) whereas that 
of hypercholesteroleaic control r a t s remained s i g n i f i -
eantly elevated (1078 + 40 ag^j 0,001 )• On 6th day 
of t reatment , the sectlonsof hypercholesterolemic control 
l i v e r (608 + 18 s t i l l showed mild l i p i d deposi t ion 
(Fig, 11) although physiological l e v e l s of hepat ic choles-
t e ro l were normal. However, in case of HMO-fed r a t s , 
(626 + 1 1 mg%) the l i v e r c e l l s show no evidence of f a t t y 
i^etamorphosis t h o u ^ EE c e l l s remain prominent i n number 
as in (Fig. 10), In choles tero l plus HMG-fed group, the 
l i v e r s sect ion on 4th day (962 + 54 mg^> were compared 
with that of pa r a l l e l cho les te ro l - fed group (125B + 40 mg,%), 
The l i v e r c e l l s of choles te ro l plus HMG-fed group r a t s 
showed no evidence of f a t t y metamorphosis ( f i g . 12) whereas 
the l i v e r c e l l s of cho les t e ro l . f ed group r a t s showed 
moderate degree of f a t t y i n f i l t r a t i o n s imi lar to those 
observed (Fig, 8 ) , 
H g . 11. Mild degree of f a t t y metamorphosis 
(H & £X 288), See text f o r d e t a i l s . 
Fig. 12. Sormal l i v e r c e l l s , f a t t y changes 
being reversed under HMG (H & EX 288). See 
tex t fo r d e t a i l s . 
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D I S C u s s i o n 
Several choles te ro l decreasing agents , e . g . , SKF 
525-A and SKP 3301-A are capable of Inducing a r eve r s ib le 
f a t t y changes of the l i v e r . On the bas i s of h i s to log ica l 
and his topathological s tud ies of UMQ-treated t i s sues of 
normocholesterolemic and hypercholesterolemic r a t s , 
( H g s , 7 to 12} the following conclusions are mades 
1, IMG-feeding did not induce euay toxic e f f e c t s 
or untoward changes within the c e l l u l a r a r c h i -
tec ture of l i v e r , h e a r t , IcLdney, adrena ls , spleen, 
ao r t a , brain and lungs. 
Feedi.D,g of f a t - r i c h choles terol d i e t to animals 
produced f a t t y metamorphosis of l i v e r s which i s 
i n agreement to e a r l i e r f ind ings (Swell and 
H i c k , 1953) ( i l g . 8 ) . 
3* As compared to hypercholesterolemic control r a t s 
(Fig« 9)t adminis t ra t ion of HMG to hypercholestero* 
lemic animals caused quicker reversa l o f l k t t y 
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changes towards normalcy ( H g . 10), 
4. The physiologicai lowering of hepat ic choles-
t e ro l leve ls i n hypercholesterolemic control 
r a t s was slower as compared to HMO-treated 
hypercholesterolemic animals on the 4th day of 
treatment (Table V). The same was found t rue 
a t the microscopic leve l a l so , as evidenced 
by the absence of foamy c e l l s i n the HMG-fed 
group as compared to foamy c e l l s i n hypercholes-
terolemic group (ELgs, 10 and 11), 
5, Administration of HMG along with choles te ro l 
did not induce any f a t t y deposit ion (Eig. 12), 
The general r i s e i n the number of hepat ic fi£ c e l l s 
of hypercholesterolemic r a t s and an appreciable increase 
i n the sec t ions of HMQ-fed r a t s i s due to operation of a 
simple defensive m e c h ^ s m , because the breakdown of 
choles terol i s known to iny.olve metabolism by r e t i c u l o -
endothel ia l system (RES)(Friedman and Byers, 1954j S t , 
George e t , 1954| Neven ^ a l , , 1956| DiLuzio, I960), 
t he re fo re agents known to s t imulate HSS funct ion may be 
e f f e c t i v e to lower the incidence of atherogenesis asso-
cia ted with hypercholesterolemia. Estrogens have been 
demonstrated to enhance the RES a c t i v i t y (Heller ^ , 
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t957), and, i n f a c t , any pro tec t ive e f f e c t of estrogens 
a ^ i n s t coronary atherogenesis had been found t o depend 
OB an i n t a c t p r o l i f e r a t i v e capacity of RES (Pick e t a l . , 
1962). Similarly the hypochoIeBterolemic ac t ion of 
hexestrol has been associated id.th increase i n fiSS a c t i v i t y 
(Boyd, 1962>. Therefore, i t i s qu i te l i ke ly that p ro tec -
t ive e f f e c t of HMa agains t hepat ic hypercholesterolemia 
and f a t t y i n f i l t r a t i o n may be a t t r i b u t e d to increase in 
RE c e l l s . 
VI. P H A f i M A C O L O G l C A L S T O D I E S 
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E X P E R I K E K T A L 
The n u t r i t i o n a l and h is topa tha logica l s tud ies 
have already shown that Hi^ I s not only e f f e c t i v e i n 
lowering the choles te ro l and other l i p i d l e v e l s of serum 
and l i v e r of normocholesterolemic and hypercholesterolemio 
r a t s hut a lso hastens recovery of the f a t t y l i v e r induced 
by feeding fat».rioh choles te ro l d i e t . During these s t u d i e s , 
no toxic of untoward e f f e c t s of HMS on the c e l l u l a r a r c h i -
tec ture of various t i s sues were observed. The compound 
was e f f e c t i v e ora l ly as well as i n t r ape r i t onea l l y • I t 
was t he r e fo r e , considered worthwhile to undertake a p re -
liminary pharmacological screening of t h i s promising 
hypocholesterolemic agent . 
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R g S 1? I T S 
Ef fec t of HMQ on BXood Pressure and fiespiration of Dog -
Bogs w e i r i n g about 12 Eg were anaesthesized in t r aven-
nously with sodium pentobarbitone (33 ffifi/Kg), The caro t id 
blood pressure was recorded. Hespiration was also recorded 
t h r o u ^ cannulated trachea by Marey*s tambour. HMG was 
administered through cannulated femoral vein. The kymo-
graphic t rac ings of the blood pressure are shown i n Fig .13. 
HH6 i n doses upto 2,0 mg/Kg did not modify the 
blood pressure , the heart r a t e and the r e s p i r a t i o n . 
Ef fec t of Ht^ on Blood Pressure of Spinal Cat - Adult 
ca t s were employed for t h i s study. The animal was anaes* 
thesized with intravenous sodium pentobarbitone (30 mg/Kg), 
The carot id ar tery was cannulated for recording the blood 
pressure on a slowly moving kymograph. The spinal cord 
was sectioned a t cerv ica l 7th segment and a r t i f i c i a l 
r e sp i r a t ion s t a r t e d through the intubated t rachea. The 
femoral vein was cannulated fo r intravenous i n j e c t i o n of 
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i l g . 13. Ef fec t of HMG on blood pressure of dog. 
See text f o r d e t a i l s . 
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HMG. HMG i n doses upto 15 did not produce any 
e f f e c t on the blood pressure of the ca t . the blood 
pressure responses to acetylchol ine} adrenal ine or h i s t a -
mine were not modified by previous administrat ion of HH6 
i n the above doses. 
I t i s c lear from the above s tudies that HMG a lso 
f a i l e d to produce any e f f e c t on blood pressure of spinal 
c a t s . 
Ef fec t of HMG on the Frog Heart i n s i t u - Ihe experiment 
was performed i n four animals. The bra in and the spinal 
cord of a f r o g was pi thed and the animal l a i d on i t s back 
and firmly f ixed to the board. The hear t was exposed and 
a cannula passed through the i n f e r i o r venacava. The apex 
of the ven t r i c l e was at tached to a hea r t - l eve r through 
a hook and thread. A small s l i t was made i n the v e n t r i c l e 
to allow the flow of the perfusion f l u i d . Prog fiinger»s 
solut ion was perfused from an open reservior in to the 
hear t and the ra t e of flow adjusted to about 40 drops per 
minute. Perfusion f l u i d containing d i f f e r e n t concentrat ions 
of HMG was allowed to flow through the h e a r t . 
HMG i n concentrat ions upto 1 i n 10,000 did not 
modify the r a t e , amplitude and the tone of the heart 
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contract ion (Hg . t 4 ) . I t did not modify the responses 
of the heart to adrenaline or acetylchol ine a l so . 
E f fec t of HMG on Smooth Muscles - Ef fec t of HMG was 
studied on i so l a t ed guinea pig ileum, rabb i t small i n t e s -
t ine and r a t u te rus , employing rout ine methods. The e f f e c t 
of HMG was tes ted against spasms induced by acetylchol ine 
and histamine and re laxa t ion produced by epinephrine. 
Varying doses of were used against each spasmogen 
and 3-4 experiments were conducted fo r each dose. 
HMG did not show any e f f e c t on the spontaneous 
contract ion of the rabbi t i n t e s t i n e , guinea pig ileum or 
r a t u t e ru s . The contract ion of the i n t e s t i n e and u te rus 
induced by acetylcholine and i t s re laxat ion induced by 
epinephrine were not modified by the addi t ion of UMG 
e i the r before or a f t e r the above drugs. The contract ion 
induced by histamine was not a f fec ted with very high doses 
of HMG (Fig. 13)* HMG (0.4 mg/ml) produces i t s own spasm. 
However, a t repeated dose no spasmogenic e f f e c t was observed. 
Acute Toxicity of liMG - was tes ted fo r acute toxic 
doses i n mice. Oral adminis t rat ion of HMG upto 1 g/Kg 
did not produce any v i s i b l e a l t e r a t i o n i n behaviour or 
H g . 14. Ef fec t of f»50 per fus ion on f r o g ' s 
h e a r t . See tex t f o r d e t a i l s . 

H g . 15. Ef fec t of HMG on i s o l a t e d guinea pig 
ileum. See text f o r d e t a i l s . 
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death in a group of 10 mice. l a another group of 9 mice 
receiving the same dose i n t r a p e r i t o n e a l l y , 4 animals 
died within the f i r s t 24 hours. 
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D I S C U S S I O H 
In oomparison to other known hypochoXesterolemlc 
and bypolipemic drugs (Holmes, 1964) which have harmful 
side effects, HMQ, In addition to its hypocholesterolemic 
and hypolipemic actions, has been found pharmacologically 
inert. It is pertinent to recall that MQ is a natural 
metabolite of liver and is known to competitively inhibit 
hepatic HMG-CoA reductase activity. Therefore as known 
for bacterial system (Wright, 1957), it may also be consi-
dered as an antimetabolite of mevalonic acid for mammalian 
systems. 
Hence, the Pharmacological inertness, of HMO, 
strongly supports the view that it may prove supezlor to 
other known hypocholesterolemic and hypolipemic drugs 
and may find a clinical use, provided in men this subs-
tance acts in the same way imd is well tolerated. A 
detailed clinical investigation is, therefore, necessary 
before the compound can be declared suitable for thera-
peutic purposes. 
s a I a n I s s H X z H s • I I A 
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E X P B a i M B H T A I > 
CfaetBioals and Beagents - Special cheiaioals obtained 
from commeroial sources used without f u r t h e r p u r i f i c a t i o n 
includedt Coenzyme A (CoA)» Crys ta l l ine bovine serum 
albumin and Glutathione (Hann Research Iiaboratories, 
(U.S.A.)} Versene (S. Merck, Germany); Tr i s (hydroxy-
methyl)<»affiino!aethane (Si^ ia Chemical Co., U.S.A.)} 2 ,6 -
dichlorophenol indophenol (Eastman Kodak, 0 .S .A. ) . 
All other chemicals used vere of A.K. grade, 
preparat ion of special reagents and chemicals was as fol lows: 
HHQ-Anhydride - This was synthesized according to the 
method of Hilz (1958). 902 mg (approximately 62 
mmoles) of HMO was ref luxed gent ly f o r one hour with 30 ml 
of anhydrous pure benzene and ml of a c e t i c anhydride. 
Excess ace t ic anhydride and benzene were removed a t 60-70^ 
under vacuum, whereupon the dark residue s o l i d i f i e d on 
cooling. The crude mater ia l was charcoaled and c rys t a l l i z ed 
twice from anhydrous benzene by allowing the hot solut ion 
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to cool o v e r n l ^ t under a soda-lime guard tube. The 
f i n e , co lo r l e s s needles M.F, « 100® (uBcorr.>| reported 
M.P. = 101-2® (uncorr , ) were stored over anhydrous CaCl^* 
HMO-Hydroxamate - 6.6 mg (45.8 jumoles) of HMO-anbydride 
vere dissolved i n 0 .3 ml of 2 M HH^ OH so lu t ion , pH 7 .0 , 
and d i lu ted to 2.00 a l a f t e r 10 minutes (Xtipiaann and 
Tu t t l e , 1945). 
Hitroprusside Heagent • 1 .5 g of sodium ni t ropruss ide 
was dissolved i n 5.0 ml of 2 H HgSO^, 95 a l of absolute 
methanol and 10 ml of 15 H IIH^ OH so lu t ion . The copious 
white p r e c i p i t a t e which resul ted was removed by f i l t r a -
t i on and the c lear orange f i l t r a t e stored a t 0®. Appea-. 
ranee of red spots immediately a f t e r treatment with 
n i t ropruss ide reagent was taken to ind ica te the presence 
of free-SH groups (Stadtman, 1957). The very f a i n t color 
produced with i^sall <|uantit ies of -SH group was i n t e n s i -
f i e d by treatment with e the r . In event of negative t e s t 
for f r e e -SH, the n i t ropruss ide dip was followed by a 
treatment with methanolic HaOH so lu t ion , ^nder a lka l ine 
condit ions the t h i o l produce a red co lor . Thus red spots 
appearing a f t e r a l k a l i treatment were assumed to be due to 
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t h i o l e s t e r s . Here agaxn weak spots were i n t e n s i f i e d 
us ing ether* 
HMQ^oA - too mg of GoA (approx. 103*0jaaoles, assuming 
755^  pu r i t y ) was dissolved i n 7,0 ml of ice-cold water and 
adjusted to pH with 1 N KOH (0.9 ml). Haiataioing the 
pB between 8 and 9 by addi t ion of £0H» H^S gas was bubbled 
t b r o u ^ the so lu t ion f o r 30 minutes to reduce any oxidisied 
CoA, Bxcess HgS was then driven of f a t pH 3-4 by Ng stream. 
At t h i s stage the q u a l i t a t i v e t e s t f o r f r e e «SH groups was 
pos i t ive and the t e s t fo r acyl t h i o l s (Stadtman, 1937) 
negs^tive. The so lu t ion was then buffered to pH 7.-5 using 
sa tura ted KHCO^  solut ion <0.6 ml) with continuous bubbling 
of HgiHMO-anhydride (approximately 20.0 mg) was then added 
t i l l the f r ee -SH t e s t was negative and the acyl t h i o l t e s t 
pos i t i ve . The reac t ion was complete within few mj.nutes. 
The pH was adjusted to 5 .0 , aad the solut ion s tored a t -15® 
and used within 3 days (Lynen, 1959). 
The pur i ty of UHO-CoA was checked oolor imetr ica l ly 
by the method pd Burr and Eudney (I960). The MMG-CoA 
prepared was only a s pure as the coenzyme used. Based on 
75^ pur i ty of CoA used, the y ie ld of HMQ-CoA was 80^. 
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Golor iae t r ic Assay of MQ-'GoA - Tbe laethod i s essen-
t i a l l y tha t of Burr and Hudney (1960>» siX of sas&ple 
containing HM0-CoA (up to 4jumoles) was aixed with ml 
of a lka l ine hydroxylamine ( f resh ly prepared by mixing equal 
volunes of 2 g. MHgOH.HCL and 2,5 H NaOH so lu t ions ) . 
Af ter one minute, 1,5 ml of FeCl^ reagent (equal p a r t s of 
0.37 M FeClj, 0 .5 H t r i ch lo roace t i c acid and 0.65 M HCl> 
was added. The colour i n t e n s i t y was determined i n a K l e t t -
Summerson photoe lec t r ic colorimeter (green f i l t e r ) . The 
standard curve used fo r color imetr ic est imation of HH6-
CoA was prepared under the above condit ions from 
hydroxamate (Fig. t 6 ) . 
Quanti ta t ive Measurement of Free Sulfhydryl Groups - The 
method of Orunertt and F h i i l i p s (1951) was used. To a 
t e s t tuhe containing 6.0 ml of sa tura ted Had solution» 
a 2 ml of sample (upto 1 jamole > containing 0.4 ml of 
metaphosphoric acid was added. Af te r 10 minutes room 
temperature, t ml of 0.067 M sodium n i t ropruss ide imd 1 ml 
of IfagCO^ * fiaCH solu t ion (equal volumes of 1.5 M IfagCO^ 
and 0.067 E ^ ^ ^ so lu t ions ) was added. The colour densi ty 
was measured witMn one minute versus a reagent blzmk i n a 
Kle t t photometer using green f i l t e r . For the ana lys i s of 
Fig. 16. Colorimetric assay of tMa-bydroxaoate. 
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*SH groups in b io log lea l samples, laetai^osphoric ac id 
was used as a deprote in iz ing agent . To quan t l t a t e the 
amount of *>SH l i b e r a t e d , GSH was used as a standard 
( i l g , 17). 
Preparat ion of Idver Homogenates (lOjS} w/V) - All 
operat ions were car r ied out a t The l i v e r s , 0,5 gt 
from each r a t of a p a r t i c u l a r group, were weighed and 
pooled together . The pooled samples were cut i n t o f i n e 
pieces and 1 g of pooled l i v e r was accurately weighed 
and t r aas fe red to a ch i l l ed Potter-Elveh^em a l l g lass 
homogeniser, containing 5 nil of 0.1 M KCl so lu t ion . The 
homogenisation was car r ied out a t slow speed fo r two 
minutes. The r e s u l t i n g thick suspension was d i lu ted with 
3.3 ml of 0.1 M KOI and 0.5 lal of 0.1 M potassium phos-
phate b u f f e r , pH 7.4 and s t i r r e d mechanically fo r 
minutes. After cen t r i fuga t ion a t 2,500 r.p.m. fo r 15 
minutes, the supernatant was used f o r the assay of HMG-* 
CoA hydrolase a c t i v i t y . 
Assay of IMS-GoA Hydrolase (EC 3 .1 .2 . ^ ) - The enzyme 
was assayed by the color imetr ic method as described 
(Beklcer e t , 1958). The assay system contained, 
i l g . 17. Standard curve for -SH est imation. 
See text f o r d e t a i l s . 








200ji2moles of Tris b u f f e r , pH 6«8, 20jamoles of versene, 
2j^moles of synthet ica l ly prepared MO-CoA* The homo-
genate to be assayed was added to th i s mixture, the f i n a l 
volume was adjusted to 2 ml with water, and the nitrogen 
was flushed in the tube, stoppered and incubated a t 
for 15 minutes. At the end of t h i s time the tube was 
placed i n i ce and the incubation mixture was deproteinissed 
by 1 ml of metaphosphorxc acid. Af ter cen t r i fuga t ion 
a t a su i tab le a l iquot of the supernatant was used f o r 
determination of l ibera ted sulfhydryl groups by n i t r o -
prusside reaction as described e a r l i e r . Controls without 
added enzyme and without added subs t ra tes were also 
included to correct fo r endogenous l i be ra t i on of s u l f -
hydryl groups. Under the assay conditions the amount of 
su l fhydryl groups released was found to be dependent over 
a l imited range on the concentration of hydrolase. 
HMG-CoA hydrolase was also assayed spectrophoto-
metr ical ly by determining the ra te of reduction of 2 ,6 -
dichlorophenol indophenol a t 600 i n a Beckman W 
spectrophotometer a t 28°. The assay system, i n a cuvette 
i n a t o t a l volume of 1.5 ml contained, lOO^moles of 
phosphate b u f f e r , pH 7 .0 , 5jumoles of versene, 0*2jttmoles 
of 2,6-diohlorophenol indophenol, the homogenate to be 
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t e s ted and 2jamoles of sfnthet ieaXly prepared ifilQ-CoA. 
The homogenate was omitted front the con t ro l . Af ter a 
4 minute preincubation period synthet ic HMG-CoA was added 
to each cuvette as the f i n a l cons t i tuen t . The r a t e of 
dye reduction a f t e r the addit ion of t h i o l e s t e r to the 
assay mixture was found to be constant f o r 4 i&inutes and 
dependent on concentrat ion of hydrolase over a l imi ted 
range. 
Prote in Estimation - fhe method used was that of Lowry 
e t a l . (1951)• In determining the pro te in concentrat ions 
of homogenates, 3 ml of 10^ t r i ch lo roace t i c acid solut ion 
was added to ml of r a t l i v e r homogenates. The precipi-
t a t e was cent r i fuged and washed successively ( three times) 
with 0.1 potassium aceta te i n alcohol^ alcohol and e ther , 
The washed p r e c i p i t a t e was dissolved i n 5 ml of 1 N laOH 
by heat ing in bo i l ing water. To t ml of a l i quo t , conta in-
ing su i t ab le quant i ty of protein« was added 5 ml of copper 
reagent and incubated at room temperature f o r 10 minutes. 
Af te r incubat ion, 0 .5 ml of d i lu ted Folin reagent ( I N ) 
was added, mixed i n s t a n t l y and color i n t ens i ty was read 
a f t e r 30 minutes i n a Klet t photometer using red f i l t e r . 
Crys ta l l ine bovine seiiim albumin so lu t ions were used as 
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standard (J^g. 18). 
Huclei Cottnts of Rat lAver Homogenates The method of 
Bass £ t (1955) was used for the coranting of nuc le i . 
A 10^ iV/7) homogenate of l i v e r i n 0*83% sa l ine so lu t ion 
vas prepared employing homogenisation time of 50 seconds 
i n a Pot ter » Elireh^eia t i s sue gr inder . Af te r homogenisa-
t ion , a 2 ml ali<iuot was mixed t h o r o u ^ l y v i t h an equal 
volume of c r y s t a l v i o l e t so lu t ion (80 mg of c r y s t a l 
v i o l e t i n 100 ml of ace t i c a c i d ) . A drop of the 
mixture was placed under the cover s l i p of a Levey* 
Hausser-counting chamber and the nuclei were enumerated. 
Five counts were made on each preparat ion and the average 
of these counts was recorded. 
Fig, 18. Standard, cunro for p ro te in detersi ination. 
See text fo r d e t a i l s . 
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Effec t of Dietary Cholesterol on Hepatic HMQ-CoA 
Hydrolase (EC 3 .1 .2 .5 ) « For determining the e f f e c t of 
d ie ta ry choles te ro l on hepatic l eve l s of HMQ-CoA hydrolase, 
two groups of young male Albino r a t s , each group conta in-
ing f i v e animals were used. In order to produce hyper-
cholesterolemia, the experimental group was maintained 
fo r two weeks on an experimental d i e t as described f o r 
Table X, The control group was kept on basal d ie t only. 
The r a t s of both the groups were a a c r i f i c e d , l i v e r s 
excised and ch i l l ed . The l i v e r s of a l l the r a t s i n a 
p a r t i c u l a r group were pooled, cut i n t o pieces and homo-
genized. The cholesterol and protein contents were 
determined, the nuclei were also counted. The hepatic 
HtKJ-^ JoA hydrolase a c t i v i t y was measured co lo r ime t r i ca l ly . 
In mixed assay, equal volumes of supernatants from 
experimental and cont ro l were mixed before enzyme assay. 
The r e s u l t s are summariaed i n Table XI, I t i s important 
to note tha t the r a t s used in th i s experiment were the 















a •H « 
o 



















0 UN 0 
w 
0 V£> 
• • • [A VO T-
eo c-• • • 
cvj f<\ tr\ 
<r~ CM 
+ 1 4-1 41 
CV» 0 if\ 
CM CM CM 
.^Ht © 0 > VO CM to r^  ® a 4-1 a 0 ifS 043 CM 00 e-t 0 lA 
4-1 4-1 
Ov IfN 03 
O 
••3 a o o 
r-4 d 











Q) S: <H o 
do 
o 3 ca ta 
o 
o 
0) a >» 

















tt 0) p. 
a 





<6 ft 3 O 
o 
2 o .a a § 
'o 












••J CI o o 
o > 
•H 
o o p< to o 
« 3 rH 
t 












P< X 0 
01 ® 
a> 
d o »4 a PI 
0 d 
P> 3 o 
108 
I t i s evident that as compared to control group 
there i s a fold increase i n the HHG-CoA hydrolase 
a c t i v i t y i n animals fed cho le s t e ro l , f a t and b i l e s a l t . 
In laixed assay a l so , there i s approximately fo ld 
increase i n the enzyme a c t i v i t y . 
i n order to see whether choles tero l feeding, 
a lone , a lso has s imi lar e f f e c t on enzyme a c t i v i t y , the 
r a t s i n experimental group were fed only 2% choles te ro l 
on basa l d ie t (on veight b a s i s ) . The control animals 
received b ^ a l d ie t only, from the analysis of hepat ic 
cho les te ro l l e v e l s , i t i s evident that increase i n choles-
t e ro l was approximately of t i ^ same magnitude as i n previous 
cases where choles te ro l and b i l e s a l t , were given by i n t u -
bat ion . The enssyme a c t i v i t y was measured by color imetr ic 
as well as spectrophotometric methods. 
the data presented i n Table XII show a 3-4 fo ld 
increase i n the HMG-^ o^A hydrolase a c t i v i t y i n choles te ro l 
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D I S C U S S I O N 
I t has been showa b^ var ious workers tha t choles* 
t e r o l feeding w i l l r e s u l t i n depression of hepat ic choles<*> 
t e r o l b iosynthes is i n animals (Gould e t a l . , 19^3} Fran tz 
Sl. s i * t 1954). The enzymatic s i t e most respons ib le f o r 
t h i s diminished a c t i v i t y has been shown to be ea r ly i n 
b iosyn the t i c pathway. @ould and Popjak (1937) observed 
tha t t h i s reac t ion s i t e i s located p r i o r to MVA. S i p e r -
s t e i n £ t a l , , (1966) and S ipe r s t e in and Fagan (1966) have 
demonstrated tha t the HMO synthe t ic pathway was not 
impaired by cho les te ro l feeding although MVA synthes is 
was diminished. Linn (1967) has provided f i r s t d i r e c t 
evidence tha t HMQ-CoA reductase (mevalonatesNABP oxido-
reductase) (acy la t ing CoA), EC 1 .1 .1 ,34) a c t i v i t y was 
depressed i n cho le s t e ro l fed r a t s . These r e s u l t s , together 
with the published works of o the rs impl ica t ing the reduc t ive 
s t ep leading to MTA format ion, are h i ^ i l y cons i s ten t with 
HMG->GoA reductase being the cont ro l enzyme fo r cho l e s t e ro l 
b iosyn thes i s . 
I l l 
I t has been suggested that the basic imlt vhich 
determines the r a t e of metabolic processes a t the c e l l u l a r 
leve l i s the enzyme-substrate complex (Krebs, 1957). Thus 
the s ize of an enzyme population and the £usount of i t s 
subs t ra te together l im i t the maximum veloc i ty vhich can 
operate under physiological condi t ion. Since our observa-
t ions show a 5-5 fo ld increase in hepatic HMCr-CoA hydrolase 
a c t i v i t y ( table XI and XII) , ve believe tha t the r i s e i n 
a c t i v i t y i s primary manifesta t ion of choles te ro l feeding; 
the secondary being the i n h i b i t i o n of HMG-CoA reductase 
a c t i v i t y by HMG released ^ vivo due to increase i n HMG-
GoA hydrolase a c t i v i t y . The increased a c t i v i t y of iOlG-
CoA hydrolase might be due to subs t ra te l eve l induct ion 
because i t i s well Icnown tha t HMG-CoA pool increases i n 
cho les te ro l - fed (Sipers te in and Fagan, 1964)i as well as 
f a s t i n g r a t s (Wieland et a l . , 1960), Prom the recent 
work of Linn (1967) a simple i n h i b i t i o n of choles tero l 
b iosynthesis by f r e e choles te ro l i s el iminated, f u r t h e r -
more the p o s s i b i l i t y of a l ipopro te in complex being the 
i n h i b i t o r , as suggested e a r l i e r (S ipers te in and Pagan, 
1964) has also been ruled out (Linn, 1967). In l i g h t of 
reported proper t ies and behaviour of cho les te ro l synthes is 
i n h i b i t o r (Migicovsky, 1962), which i s very s imi lar to 
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HMG, and the f a c t that HMG i s known to i n h i b i t the 
choles te ro l biosynthesis together v i t h our observat ions, 
i t i s qu i t e l ike ly that HMO i s the ac tua l i n h i b i t o r of 
choles te ro l synthes is . I t appears more reasonable t h a t , 
i n viyo, H ^ exer ts i t s i nh ib i to ry e f f e c t i n bound form. 
Support to t h i s hypothesis i s a^ain obtained from the work 
of Migicovsky (1964) who had shown that the i n h i b i t o r i s 
bound with pro te in . 
Therefore, i t may be concluded tha t as suggested 
e a r l i e r (Siddiqi , 1962) choles tero l feed-back control 
might ac t by increas ing the a c t i v i t y of HMG-GoA hydrolase, 
thereby increas ing f r e e HMG and decreasing choles te ro l 
biosynthesis due to simple subs t ra te analog competition. 
VIII . S U M M A R Y 
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On the bas is of n u t r i t i o n a l s t ud i e s , i t has been 
demonstrated that HMG not only decreases serum t o t a l 
cho les t e ro l , e s t e r cho les te ro l , but a lso s i g n i f i c a n t l y 
lowers t o t a l e s t e r i f i e d f a t t y ac ids , phospholipids and 
t r i g lyce r ide s of hypercholesterolemic r a t s . In case of 
no3:^ocholesterolemic animals, however, HMG has sii&ilar 
e f f e c t except tha t l eve l s of phospholipids resoain un-
changed. I t i s a lso e f f e c t i v e in supressing experiiaen-
t a l l y induced hypercholesterolemia i n serum as well as 
in l i v e r . 
HMG induces no toxic e f f e c t a t the microscopic 
l e v e l , and also hastens the reversal of f a t t y i n f i l t r a t i o n 
of l i v e r , furthermore, the pharmacological observations 
suggest that t&lG i s i n e r t . Hence i t may be considered 
superior to most of the known hypocholesteroleoic and 
hypolipemic drugs in use a t present . 
The increase i n hepatic HMG-CoA hydrolase a c t i v i t y 
i n choles tero l - fed r a t s has suggested timt die tary choles-
t e ro l causes subst ra te l eve l induction of the enzyme 
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a c t i v i t y and the HH6 thus released ^ v x y o i n h i b i t s HMG-
CoA reductase ac t iv i ty* This may a l so explain why choles-
t e ro l - f eed ing blocks endogenous choles te ro l synthes is . 
Although i t i s premature to pred ic t the esact mode 
of ac t ion of ifilQ, the present work i s the f i r s t attempt 
to demonstrate the hypocholesterolemic and hypolipemlc 
ac t ions of HMQ* 
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Hypocholesterolemic Effect of 
3-Hydroxy-3-methylglutaric Acid 
In bacter ia l system, 3-h5/drox^-3 methylg lu ta r ic acid 
(HMG) has been evaluated as an an t imetabol i te of 
mevalonic acid^ Fimognvt'i^  has shown t h a t HMG 
inhibi ts the incorporat ion of ace ta te into mevalona tc in 
r a t liver prepara t ions 1 hi-i m a v explain the HMG in-
hibi t ion of cholesterol synthesis f rom acetato as described 
by Rabixowitz and Glti^ ' There is certain ra t iona le 
to the fac t t h a t a compound active as an inhibi tor of 
cholesterol biosynthesis mav have ut i l i ty in t he t rea t -
men t of hvpercholesterolemia and atherosclerosis e g 
nicotinic acid^, a p h e n j lbut \ ric acid and a -p -b iphen j 1-
b u t \ r i c acid'i This p rompted us to invest igate t he hypo-
cholesterolemic p r o p o r t j of HAIG in normal as %\ell as 
hypercholesterolemic animals 
Materials and methods 4 gioups ot young male albino 
rats , C D R l strain® wcigl ing 50 g and each group 
containing 6 animals «er ( selected for exper imenta l 
studies (Table 1) Group I .is kep t as control and fed on 
basal d i e t ' In addi t ion to thi« diet, groups I I I I I and IV 
received orally, vary ing doses of HAIG in wate r (as 
indicated) for 7 or 14 da\'= Vt the end of t r ea tmen t , the 
to ta l serum cholesterol ^\a5 determined b y Bloor 's 
method For s tudies made in Table I I , young male 
albino ra t s weighing about 100 g were mainta ined for 2 
w eeks on an exper imenta l di( t (basal diet containing 2 % 
hydrogena ted vegetable oils 20 mg cholesterol and 10 
mg sodium cholate as homogeneous water suspension, by 
in tubat ion) in order to proiluce hypercholesterolemic 
conditions The serum cholesterol level of such ra t s was 
found to be s igmf ican th elevated (192 19 m g % , 
p < 0 001) as compared to ra ts kep t on basal diet only 
(118 5 m g % ) The ra ts >\ere then d u i d e d into groups 
ot 5 each The cholesterol-fed and cholesterol plus HMG-
fcd groups cont inued receiving exper imenta l diet How-
ever in addi t ion t he lat tei group received 50 mg 
HMG/kg /day m water The exper imenta l diet was re-
placed by basal diet for h > percholesterolemic control 
1 
g r o u p s a n d H M G - f c d g r o u p s T h e l a t t e r r e c e i v e d 50 m g 
H M G / k g / d a y i n w a t e r v a r j i n g p e r i o d s of H M G t r e a t -
m e n t (as i n d i c a t e d ) , t h e s e r u m c h o l e s t e r o l w a s d e t e r m i n e d 
Results F r o m T a b l e I is e v i d e n t t h a t H M G a d m i n i s t r a -
t i o n t o n o r m a l r a t s f o r 1 o r 2 w e e k s s i g n i f i c a n t l y l o w e r s 
t h e t o t a l s e r u m c h o l e s t e r o l c o n t e n t F r o m t h e s t a t i s t i c a l 
e v a l u a t i o n of t h e d a t a p r e s e n t e d in T a b i c I I , i t b e c o m e s 
l ab le 1 Effect of H"\I& feeding on serum cholesterol of normal rats'* 
Group \ o 
I II I I I IV 
I rea tment 
Basal diet Basal diet 
-1- 10 mg 
H-^IG" 
Basal diet 
^ 20 mg 
HMG 
Basal diet 
+ 30 mg 
HMG 
7 d a j s 
14 d a \ s 
151 ± 1 0 
164 ± 4 
145 ± 2 
147 i 3" 
136 ± 5 
133 ± 
128 ± 5 •• 
130 ± 9 = 
All figures arc a\ er.ige \ alues expressed as total cholesterol content 
m mg% with standard error, ' ' dose of HMG/kg/da\ , "^difference 
as compared nith control group statistically significant p < 0 05, 
''fi<0 01,<^pc0 001 
Table II Effect o HMG and cholesterol + HMG feeding on serum 
cholesterol of h-.percholesterolemic rats (a\crage ± S E ) 
HMG Total chole< terol content, mg% 
treatment 







1st 207 ± 10 139 ± 200 ± 6 133 ± 
2nd 203 ± 4 129 ± 15 = 181 ± 4 138 ± 4 " 
3rd 208 ± 2 172 ± 8'' 192 ± 6 165 ± 4a 
4th - - 181 ± 5 148 ± 3" 
5th 211 ± 14 167 ± 5" 158 ± 5 162 ± 4 
6th - - 139 i 5 137 ± 7 
^ Difference as comp ired to respecti\ e control group statistically 
significant / > < 0 001, '>;i = 0 01 
Reprinted from Lhc Indian Jojininl of Biochemistry, 1967, 
Vol. 4, No. 2 (Suppl.: Abstracts of papers presented at the 
International Convention of Biochemists, Bangalore), 
pp. 31-32 
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In bacterial system, 3-hydroxy-3-methylglutaric acid (HMG) 
has been evaluated as an antimetabolite of mevalonic acid'. 
Fimognari^ has sho^vn that HMG inhibits the incorporation 
of acetate into mevalonate in rat liver preparations. This 
may explain the HMG inhibition of cholesterol synthesis from 
acetate as described by Rabinowitz and Gurin®. There is 
certain rationale to the fact that a compound active as an 
inhibitor of cholesterol biosjmthesis may have utility in the 
treatment of hypercholesterolemia and atherosclerosis, e.g. 
nicotinic acid', a-phenylbutyric acid and a-/)-biphenylbutyric 
acid'5. This prompted us to investigate the hypocholestero-
lemic property of HMG in normal as well as hypercholes-
terolemic animals. We have shown that administration 
(both orally and intraperitoneally) of HMG causes significant 
depression of serum and liver cholesterol levels of normal as 
well as hypercholesterolemic rats®. However, it is interesting 
to mention that in normal rats there is no decrease in liver 
cholesterol content. To further strengthen this effect of 
HMG, the effect of combined feeding of HMG and cholesterol 
on serum and liver cholesterol content was studied. The 
data reveal that the combined feeding of HMG along with 
cholesterol does not permit rise in serum as well as liver 
cholesterol levels; on contrary, it causes 36 per cent and 
40 per cent decrease in serum and liver cholesterol levels 
respectively, as compared to cholesterol-fed controls. I t has 
also been shown that HMG-feeding not only decreases total 
cholesterol content but also causes reduction in esterified 
cholesterol, total esterified fatty acids, and 
triglycerides content of serum in normal as well as hyper-
cholesterolemic rats. 
The histopathological studies show that HMG-feeding to 
hypercholesterolemic rats did not bring any adverse effect 
at the cellular organization of the tissue'. On contrarj-, HMG 
treatment of experimental animals causes quicker reversal of 
the fat.ty changes m liver, towards normalcy as compared to 
those animals in which the physiological lowering of choles-
terol took place on its own accord. 
The enzyme studies have demonstrated that cholesterol 
feodmg increases HMG-Co V hydrolase acti\ ity « i th H effect 
on HMG-CoA reductase activity HMG-feedmg does not 
allow an}r increase or decrease of HMG-CoA hydrolase activity. 
These investigations, coupled with the hypocholesterolomic 
property of HMG, suggest that HMG, like other inhibitors o£ 
cholesterol biosynthesis, may find a use in the treatment of 
hypercholesterolemia The possible mechanism for hypo-
cholesterolemic action (jf HMG will be discussed. 
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clear t h a t H M G feeding cduses a signif icant depression m 
serum cholesterol levels of HMG-fed groups as compared 
to parallel hyperchoks te io lemic control groups I t \ \as 
also observed t h a t combined feeding of cholesterol along 
w i th HMG also significantly^ declines the serum cholesterol 
levels as compared 1o parallel cholesterol-fed groups 
I h i s f u r t h e r suppor ts the hvpocholesterolemic p roper ty 
of HAIG I t IS interest ing to ment ion t h a t no appa ren t 
h a r m f u l effects of HMG ieeding were noticed on animals 
dur ing the course of investigation F r o m other works i t is 
known t h a t , in vivo, H M G arises f rom HMG-CoA by the 
action of HMG-CoA hydrolase (EC 3 1 2 5), which s t rongly 
and compet i t ively inhibi ts the HMG-CoA reductase (EC 
1 1 1 34) ac t iv i ty in bacterial® as well as r a t liver prepara-
tions^ These observations, coupled wi th the hypo-
cholesterolemic p roper ty of HMG, suggest t h a t HMG, like 
other inhibitors of cliolesterol biosynthesis, m a y find a 
use m the t rea tment of hypercholesterolemia provided 
t h a t in men th is substance acts in the same w a y and is 
well tolerated I he detailed pharmacological screening of 
this compound is in pi ogress and w ill be repor ted else-
where in detail ' ' 
Zusammenfassung Bei F u t t e r u n g mi t 3-hydroxy-3-
methylg lu ta rsaure (HJLG) wurde eme bedeutende Sen-
kung des Serum-Cholestermspiegels sowohl in normalen, 
als auch in hypercholes term amischen R a t t e n beobachte t 
Bei gleichzeitiger Verabreichung von H M G und Chol-
esterol bheb die erwar le te Zunahme beim Serumchol-
osterin aus und gleichzeitig wurde eme \ b n a h m e des 
Cholestermspiegels fc stgestellt 
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